8-K
false000163297000016329702026-11-052026-11-05

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 05, 2026

 

 

American Healthcare REIT, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Maryland

001-41951

47-2887436

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

18191 Von Karman Avenue, Suite 300

 

Irvine, California

 

92612

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 949 270-9200

 

Not Applicable

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.01 par value per share

 

AHR

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 2.02 Results of Operations and Financial Condition.

On November 5, 2026, we issued an earnings release announcing our financial position as of September 30, 2026 and our results for the quarter then ended. A copy of the earnings release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

 

Item 7.01 Regulation FD Disclosure.

 

On November 5, 2026, we released certain supplemental data and a presentation for the quarter ended September 30, 2026. A copy of the supplemental data is attached hereto as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein. Additionally, a copy of the presentation is available on the Investor Relations page of the Company’s website at https://ir.americanhealthcarereit.com/events-and-presentations/.

 

The information contained in Items 2.02 and 7.01 hereof, including Exhibits 99.1 and 99.2 incorporated by reference herein, is being “furnished” and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by the specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description

99.1

American Healthcare REIT, Inc. Earnings Release, dated November 5, 2026

99.2

 

American Healthcare REIT, Inc. Third Quarter 2026 Supplemental

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

American Healthcare REIT, Inc.

 

 

 

 

Date:

November 5, 2026

By:

/s/ Jeffrey T. Hanson

 

 

 

Name: Jeffrey T. Hanson
Title: Chief Executive Officer and Chairman of the Board of Directors

 


 

img32265050_0.gif

 

Exhibit 99.1

 

 

r

Press Release

 

 

 

Irvine, CA – November 5, 2026

Contact: Alan Peterson

Email: investorrelations@ahcreit.com

 

American Healthcare REIT Announces Third Quarter 2026 Results;

Increases Full Year 2026 Guidance

American Healthcare REIT, Inc. (NYSE: AHR) (the “Company,” “we,” “our,” “us,” “management,” or "AHR") is announcing today its third quarter 2026 results and increasing full year 2026 guidance.

Key Highlights

(all figures reported for the three months ended September 30, 2026 and percentage changes are compared to the same period in 2025 unless otherwise noted)

•
GAAP net income attributable to controlling interest of $31.2 million, or $0.14 per diluted share.
•
Normalized Funds From Operations attributable to controlling interest (“NFFO”) of $0.58 per diluted share.
•
Achieved total portfolio Same-Store Net Operating Income (“Same-Store NOI”) growth of 13.8%.
•
Achieved Same-Store NOI growth of 28.2% and 15.7% in its senior housing operating properties (“SHOP”) and integrated senior health campuses (“ISHC”) segments, respectively.
•
Acquired approximately $1.69 billion of new investments within its SHOP segment. Since the beginning of 2026, the Company has completed approximately $2.07 billion in new investments.
•
Increased total portfolio Same-Store NOI growth guidance to 12.0% to 14.0% and NFFO per diluted share guidance to $2.23 to $2.26 for the year ending December 31, 2026.
•
Completed a follow-on common equity offering in August 2026, entering into forward sale agreements relating to 15,237,500 shares of common stock for approximately $819.0 million in gross proceeds.
•
Entered into forward sale agreements pursuant to its at-the-market equity offering program ("ATM Program"), to sell 14,385,140 shares of common stock for approximately $780.5 million in gross proceeds. Subsequent to quarter end, we entered into additional forward sale agreements pursuant to its ATM Program to sell 1,522,952 shares of common stock for approximately $77.1 million in gross proceeds, assuming full physical settlement.
•
As of November 5, 2026, pursuant to its ATM Program and its August 2026 follow-on common equity offering, the Company had unsettled forward sale agreements outstanding relating to 24,598,011 shares of common stock that would result in approximately $1.32 billion in gross proceeds assuming full physical settlement.
•
Reported a 0.6x improvement in Net Debt-to-Annualized Adjusted EBITDA to 1.9x as of September 30, 2026, from 2.5x as of June 30, 2026.
•
Strengthened the senior leadership team as Jeff Hanson was named Chief Executive Officer in addition to continuing to serve as Chairman, Gabe Willhite was elevated to President in addition to continuing to serve as Chief Operating Officer, and Scott Estes was appointed Lead Independent Director. The Company also added Aric Chang as Chief Financial Officer, Jon Crosier as Chief Technology Officer and Ann Lacey as Executive Vice President, Portfolio and Asset Management – Senior Housing.
•
Published 2025 Corporate Responsibility report committing to a 25% reduction in greenhouse gas Scope 1 and 2 emissions intensity by 2033 from a 2024 base year.
•
Recognized for workplace quality and corporate trust by Great Place To Work, Newsweek, U.S. News & World Report, and Fortune.

“We strengthened three things this quarter: the team, the portfolio and the platform that connects them,” said Jeff Hanson, the Company’s Chairman and Chief Executive Officer. “We added executive leadership across finance, asset management, and technology, added nearly $2.1 billion of new investments in 2026, and brought new operating partners onto a platform that pairs their local expertise with portfolio-wide collaborations among the top operators in the senior housing industry. Importantly, this growth has been ambitious but disciplined. Superior care quality drives resident outcomes, and resident outcomes drive our performance. Our goal remains to be the preferred capital partner for the best senior housing operators in America, and we believe we made great strides in furtherance of that objective this quarter.”

Page | 1


 

Third Quarter 2026 Results

The Company’s Same-Store NOI growth results for the three and nine months ended September 30, 2026 are detailed below. Same-Store NOI growth in the third quarter of 2026, compared to the same period in 2025, was led by the Company’s operating portfolio, comprised of its ISHC and SHOP segments, through strong pricing power driven by rate growth and effective expense control by its operating partners.

Three Months Ended September 30, 2026 Relative to Three Months Ended September 30, 2025

 

Segment

Same-Store NOI Growth

 

ISHC

 

15.7

%

SHOP

 

28.2

%

Outpatient Medical

 

0.4

%

Triple-Net Leased Properties

 

2.7

%

Total Portfolio

 

13.8

%

 

Nine Months Ended September 30, 2026 Relative to Nine Months Ended September 30, 2025

 

Segment

Same-Store NOI Growth

 

ISHC

 

15.5

%

SHOP

 

22.9

%

Outpatient Medical

 

1.2

%

Triple-Net Leased Properties

 

3.1

%

Total Portfolio

 

13.1

%

 

"Supply and demand dynamics alone do not guarantee success in this business," said Gabe Willhite, AHR's President and Chief Operating Officer. "Together with our roster of top regional operators, we executed on occupancy gains, dynamic pricing management and tight expense control to deliver 28.2% Same-Store NOI growth in SHOP and 15.7% in ISHC. We closed the third quarter with a solid foundation to enter the last quarter of 2026, which we believe should support growth entering 2027. The systems and standards we continue to support with our operating partners have propelled growth across our SHOP+ portfolio, which is comprised of our SHOP and ISHC segments."

Transactional Activity

During the three months ended September 30, 2026, the Company:

•
Acquired 17 new SHOP assets for approximately $1.69 billion, as previously announced. The properties are located in various states and will be managed and operated by new and existing regional operating partners.
•
Funded a loan for seven properties for approximately $86.2 million with purchase options to acquire the properties, as previously announced. The properties are currently operated by one of the Company's existing tenants who leases other buildings within its Triple-Net Leased Properties segment.

Following the Company's completed transaction activity during the three months ended September 30, 2026, and subsequent to quarter end, the Company's investment pipeline consists of over $1.0 billion which includes newly awarded deals and deals in the pipeline previously disclosed in the Company's Second Quarter 2026 Earnings Release that have yet to close. While the Company expects to close the deals in its investment pipeline by the end of the first quarter in 2027, it cannot guarantee when or if these closings will take place. Therefore, the Company is not including any additional transaction activity, including the awarded deals in its investment pipeline, in its 2026 guidance, beyond the transactions disclosed as completed.

Development Activity

The Company's total in-process development and expansion pipeline is expected to cost approximately $192.9 million, of which $88.2 million had been funded as of September 30, 2026.

Capital Markets and Balance Sheet Activity

As of September 30, 2026, the Company had total consolidated indebtedness of $1.38 billion and approximately $2.35 billion of total liquidity, comprised of cash and cash equivalents, undrawn capacity on its lines of credit, and expected gross proceeds from unsettled forward sale agreements, assuming full physical settlement. The Company's Net-Debt-to-Annualized Adjusted EBITDA as of September 30, 2026, was 1.9x.

Page | 2


 

During the three months ended September 30, 2026, the Company entered into forward sale agreements pursuant to its ATM Program, to sell 14,385,140 shares of common stock for approximately $780.5 million in gross proceeds. Subsequent to quarter end, the Company entered into additional forward sale agreements pursuant to its ATM Program to sell 1,522,952 shares of common stock for approximately $77.1 million in gross proceeds, assuming full physical settlement.

The Company also completed a follow-on common equity offering in August 2026, entering into new forward sale agreements to issue 15,237,500 shares of common stock for gross proceeds of approximately $819.0 million.

During the three months ended September 30, 2026, the Company issued 36,833,346 shares of common stock to physically settle sales under forward sale agreements pursuant to its ATM Program and its May 2026 and August 2026 follow-on common equity offerings for gross proceeds of approximately $1.88 billion. Subsequent to quarter end, the Company issued an additional 589,179 shares of common stock to physically settle sales under forward sale agreements from its ATM Program and its August 2026 follow-on common equity offering for gross proceeds of approximately $31.2 million. As of November 5, 2026, pursuant to its ATM Program and its August 2026 follow-on common equity offering, the Company had unsettled forward sale agreements outstanding relating to 24,598,011 shares of common stock that would result in approximately $1.32 billion in gross proceeds assuming full physical settlement.

“I am honored to join AHR at a pivotal moment for the Company and sector. AHR’s focus resonated with me: to serve a rapidly growing senior population by supporting top operators who deliver the best care,” said Aric Chang, the Company's Chief Financial Officer. “Our team and operating partners successfully executed on organic and external growth in the third quarter, which is why we are raising full-year guidance for Same-Store NOI growth and NFFO per diluted share. At the midpoint of revised guidance, we now expect 31% NFFO per diluted share growth over 2025, reflecting our continued focus on driving long-term shareholder value.”

Full Year 2026 Guidance

The Company is increasing NFFO per diluted share and Same-Store NOI growth guidance for the year ending December 31, 2026. The Company's 2026 guidance does not assume additional transaction or capital markets activity beyond the transactions or activity disclosed herein as completed. Guidance ranges are detailed below:

 

Full Year 2026 Guidance

Metric

Midpoint

Current FY 2026 Range

Prior FY 2026 Range

Net income per diluted share

$0.605

$0.59 to $0.62

$0.54 to $0.58

NAREIT FFO per diluted share

$2.145

$2.13 to $2.16

$2.04 to $2.08

NFFO per diluted share

$2.245

$2.23 to $2.26

$2.15 to $2.19

Total Portfolio SS NOI Growth

13.0%

12.0% to 14.0%

11.0% to 13.0%

Segment-Level SS NOI Growth:

 

 

 

ISHC

15.5%

14.5% to 16.5%

13.0% to 16.0%

SHOP

24.5%

23.0% to 26.0%

18.0% to 21.0%

Outpatient Medical

0.75%

0.5% to 1.0%

0.0% to 1.0%

Triple-Net Leased Properties

3.0%

2.5% to 3.5%

2.0% to 3.0%

________________________________________

Certain of the assumptions underlying the Company’s 2026 guidance can be found within the Non-GAAP reconciliations in this earnings release and in the appendix of the Company’s Third Quarter 2026 Supplemental Financial Information (“Supplemental”). A reconciliation of net income (loss) calculated in accordance with generally accepted accounting principles in the United States ("GAAP") to NAREIT FFO and NFFO can be found within the Non-GAAP reconciliations in this earnings release. Non-GAAP financial measures and other terms, as used in this earnings release, are also defined and further explained in the Supplemental. The Company is unable to provide, without unreasonable effort, guidance for the most comparable GAAP financial measures of total revenues and property operating and maintenance expenses. Additionally, a reconciliation of the forward-looking non-GAAP financial measures of Same-Store NOI growth to the comparable GAAP financial measures cannot be provided without unreasonable effort because the Company is unable to reasonably predict certain items contained in the GAAP measures, including non-recurring and infrequent items that are not indicative of the Company’s ongoing operations. Such items include, but are not limited to, impairment on depreciated real estate assets, net gain or loss on sale of real estate assets, stock-based compensation, casualty loss, non-Same-Store revenue and non-Same-Store operating expenses. These items are uncertain, depend on various factors and could have a material impact on the Company’s GAAP results for the guidance period.

 

 

Page | 3


 

Distributions

As previously announced, the Company’s Board of Directors declared a cash distribution for the quarter ended September 30, 2026 of $0.25 per share of its common stock. The third quarter distribution was paid in cash on October 16, 2026, to stockholders of record as of September 30, 2026.

Supplemental Information

The Company has disclosed supplemental information regarding its portfolio, financial position and results of operations as of, and for the three and nine months ended, September 30, 2026, and certain other information, which is available on the Investor Relations section of the Company's website at https://ir.americanhealthcarereit.com.

Conference Call and Webcast Information

The Company will host a webcast and conference call at 1:00 p.m. Eastern Time on November 6, 2026. During the conference call, Company executives will review third quarter 2026 results, discuss recent events and conduct a question-and-answer period.

To join via webcast, investors may use the following link: https://events.q4inc.com/attendee/980250267.

To join the live telephone conference call, please dial one of the following numbers at least five minutes prior to the start time:

North America Toll-Free: +1 833-461-5787
International Toll: +1 585-542-9983
International Dial-Ins:
https://help.events.q4inc.com/eahc/international-dial-in-numbers
Meeting ID: 980 250 267

A digital replay of the call will be available on the Investor Relations section of the Company’s website at https://ir.americanhealthcarereit.com shortly after the conclusion of the call.

Forward-Looking Statements

Certain statements contained in this press release, including statements relating to the Company's expectations regarding its performance and growth in 2027; full year 2026 guidance, including net income per diluted share, NAREIT FFO per diluted share, NFFO per diluted share, total portfolio Same-Store NOI growth, and segment-level Same-Store NOI growth and margin expansion; purchases and sales of assets, including the timing of the closing of deals in its investment pipeline; development plans; the settlement of forward sale agreements; emissions reduction targets and the benefits of additions to its management team, portfolio and platform may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends for all such forward-looking statements to be covered by the applicable safe harbor provisions for forward-looking statements contained in those acts. Such forward-looking statements generally can be identified by the use of forward-looking terminology, such as “may,” “will,” “can,” “expect,” “intend,” “anticipate,” “estimate,” “believe,” “continue,” “possible,” “initiatives,” “focus,” “seek,” “objective,” “goal,” “strategy,” “plan,” “potential,” “potentially,” “preparing,” “projected,” “future,” “long-term,” “once,” “should,” “could,” “would,” “might,” “uncertainty” or other similar words. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Any such forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which the Company operates, and beliefs of, and assumptions made by, the Company's management and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied therein, including, without limitation, changing macroeconomic, domestic legal and fiscal policies; geopolitical conditions and other risks disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 27, 2026, and subsequent periodic reports filed with the Securities and Exchange Commission. Except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statements contained in this release.

 

 

 

 

Page | 4


 

Non-GAAP Financial Measures

The Company’s reported results are presented in accordance with GAAP. The Company also discloses the following non-GAAP financial measures: EBITDA, Adjusted EBITDA, Net Debt-to-Annualized Adjusted EBITDA, NAREIT FFO, NFFO, NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI. The Company believes these non-GAAP financial measures are useful supplemental measures of its operating performance and are used by investors and analysts to compare the operating performance of the Company between periods and to other REITs or companies on a consistent basis without having to account for differences caused by unanticipated and/or incalculable items. Definitions of the non-GAAP financial measures used herein and reconciliations to the most directly comparable financial measure calculated in accordance with GAAP can be found at the end of this earnings release. See below and "Definitions" for further information regarding the Company's non-GAAP financial measures.

EBITDA and Adjusted EBITDA

Management uses earnings before interest, taxes, depreciation and amortization (“EBITDA”) and Adjusted EBITDA to facilitate internal and external comparisons to our historical operating results and in making operating decisions. EBITDA and Adjusted EBITDA are widely used by investors, lenders, credit and equity analysts in the valuation, comparison, and investment recommendations of companies. Additionally, EBITDA and Adjusted EBITDA are utilized by our Board of Directors to evaluate management. Neither EBITDA nor Adjusted EBITDA represents net income (loss) or cash flows provided by operating activities as determined in accordance with GAAP and should not be considered as alternative measures of profitability or liquidity. In addition, management uses Net Debt-to-Annualized Adjusted EBITDA as a measure of our ability to service our debt. Finally, EBITDA and Adjusted EBITDA may not be comparable to similarly titled items reported by other REITs or other companies.

NAREIT Funds from Operations (FFO) and Normalized Funds from Operations (NFFO)

We believe that the use of FFO, which excludes the impact of real estate-related depreciation and amortization and impairments, provides a further understanding of our operating performance to investors, industry analysts and our management, and when compared year over year, reflects the impact on our operations from trends in Occupancy rates, rental rates, operating costs, general and administrative expenses and interest costs, which may not be immediately apparent from net income (loss) as determined in accordance with GAAP. However, FFO and NFFO should not be construed to be (i) more relevant or accurate than the current GAAP methodology in calculating net income (loss) as an indicator of our operating performance, (ii) more relevant or accurate than GAAP cash flows from operations as an indicator of our liquidity or (iii) indicative of funds available to fund our cash needs, including our ability to make distributions to our stockholders. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the non-GAAP FFO and NFFO measures and the adjustments to GAAP in calculating FFO and NFFO. Presentation of this information is intended to provide useful information to investors, industry analysts and management as they compare the operating performance metrics used by the REIT industry, although it should be noted that some REITs may use different methods of calculating funds from operations and normalized funds from operations, so comparisons with such REITs may not be meaningful.

Net Operating Income (NOI)

We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are appropriate supplemental performance measures to reflect the performance of our operating assets because NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI exclude certain items that are not associated with the operations of the properties. We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are widely accepted measures of comparative operating performance in the real estate community and are useful to investors in understanding the profitability and operating performance of our property portfolio. However, our use of the terms NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts.

NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are not equivalent to our net income (loss) as determined under GAAP and may not be a useful measure of operational income or cash flows. Furthermore, NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be considered as alternatives to net income (loss) as an indication of our operating performance or as an alternative to cash flows from operations as an indication of our liquidity. NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be construed to be more relevant or accurate than the GAAP methodology in calculating net income (loss). NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should be reviewed in conjunction with other measurements as an indication of our performance.

Page | 5


 

About American Healthcare REIT, Inc.

American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing communities, skilled nursing facilities, and outpatient medical buildings across the United States, and in the United Kingdom and the Isle of Man.

Page | 6


 

AMERICAN HEALTHCARE REIT, INC.

 

CONDENSED CONSOLIDATED BALANCE SHEETS

As of September 30, 2026 and December 31, 2025

(In thousands, except share and per share amounts) (Unaudited)

 

September 30,
2026

 

 

December 31,
2025

 

ASSETS

 

Real estate investments, net

 

$

5,949,084

 

 

$

4,183,419

 

Debt investments, net

 

 

240,808

 

 

 

92,136

 

Cash and cash equivalents

 

 

222,767

 

 

 

114,836

 

Restricted cash

 

 

35,905

 

 

 

36,917

 

Accounts and other receivables, net

 

 

228,503

 

 

 

204,313

 

Identified intangible assets, net

 

 

370,206

 

 

 

253,236

 

Goodwill

 

 

234,942

 

 

 

234,942

 

Operating lease right-of-use assets, net

 

 

149,524

 

 

 

135,399

 

Other assets, net

 

 

177,618

 

 

 

171,028

 

Total assets

 

$

7,609,357

 

 

$

5,426,226

 

 

 

 

 

 

 

LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY

 

Liabilities:

 

 

 

 

 

 

Mortgage loans payable, net

 

$

814,957

 

 

$

966,925

 

Lines of credit and term loan, net

 

 

549,927

 

 

 

549,761

 

Accounts payable and accrued liabilities

 

 

372,123

 

 

 

317,742

 

Identified intangible liabilities, net

 

 

1,717

 

 

 

2,110

 

Financing obligations

 

 

19,208

 

 

 

33,902

 

Operating lease liabilities

 

 

135,430

 

 

 

135,603

 

Security deposits, prepaid rent and other liabilities

 

 

66,538

 

 

 

59,568

 

Total liabilities

 

 

1,959,900

 

 

 

2,065,611

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

Redeemable noncontrolling interests

 

 

66,810

 

 

 

—

 

 

 

 

 

 

 

Equity:

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Preferred stock, $0.01 par value per share; 200,000,000 shares authorized;
   none issued and outstanding

 

 

—

 

 

 

—

 

Common stock, $0.01 par value per share; 1,000,000,000 shares authorized;
   231,479,253 and 185,911,442 shares issued and outstanding as of
   September 30, 2026 and December 31, 2025, respectively

 

 

2,311

 

 

 

1,852

 

Additional paid-in capital

 

 

7,164,243

 

 

 

4,880,169

 

Accumulated deficit

 

 

(1,628,682

)

 

 

(1,559,279

)

      Accumulated other comprehensive loss

 

 

(2,205

)

 

 

(2,104

)

Total stockholders’ equity

 

 

5,535,667

 

 

 

3,320,638

 

Noncontrolling interests

 

 

46,980

 

 

 

39,977

 

Total equity

 

 

5,582,647

 

 

 

3,360,615

 

Total liabilities, redeemable noncontrolling interests and equity

 

$

7,609,357

 

 

$

5,426,226

 

 

 

 

 

 

Page | 7


 

AMERICAN HEALTHCARE REIT, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

For the Three and Nine Months Ended September 30, 2026 and 2025

(In thousands, except share and per share amounts) (Unaudited)

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

Resident fees and services

 

$

701,093

 

 

$

532,058

 

 

$

1,945,379

 

 

$

1,530,519

 

Real estate revenue

 

 

41,056

 

 

 

40,879

 

 

 

121,794

 

 

 

125,524

 

Total revenues

 

 

742,149

 

 

 

572,937

 

 

 

2,067,173

 

 

 

1,656,043

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Property operating expenses

 

 

564,735

 

 

 

454,530

 

 

 

1,601,744

 

 

 

1,313,238

 

Rental expenses

 

 

12,619

 

 

 

12,592

 

 

 

37,892

 

 

 

39,225

 

General and administrative

 

 

21,582

 

 

 

14,108

 

 

 

59,078

 

 

 

42,206

 

Transaction, transition and restructuring costs

 

 

5,113

 

 

 

50

 

 

 

9,870

 

 

 

1,808

 

Depreciation and amortization

 

 

90,869

 

 

 

49,181

 

 

 

230,056

 

 

 

132,236

 

Total expenses

 

 

694,918

 

 

 

530,461

 

 

 

1,938,640

 

 

 

1,528,713

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

(17,773

)

 

 

(20,392

)

 

 

(55,195

)

 

 

(65,969

)

(Loss) gain in fair value of derivative financial instruments

 

 

(106

)

 

 

166

 

 

 

1,778

 

 

 

(1,213

)

Gain (loss) on dispositions of real estate investments, net

 

 

—

 

 

 

691

 

 

 

5,647

 

 

 

(2,344

)

Impairment of real estate investments

 

 

—

 

 

 

(3,768

)

 

 

(2,137

)

 

 

(38,133

)

Income (loss) from unconsolidated entities

 

 

49

 

 

 

462

 

 

 

1,733

 

 

 

(2,624

)

Gain on re-measurement of previously held equity interest

 

 

—

 

 

 

14,580

 

 

 

—

 

 

 

14,580

 

Foreign currency (loss) gain

 

 

(619

)

 

 

(977

)

 

 

(1,363

)

 

 

3,181

 

Other income, net

 

 

3,473

 

 

 

2,309

 

 

 

7,722

 

 

 

5,314

 

Total net other expense

 

 

(14,976

)

 

 

(6,929

)

 

 

(41,815

)

 

 

(87,208

)

Income before income taxes

 

 

32,255

 

 

 

35,547

 

 

 

86,718

 

 

 

40,122

 

Income tax (expense) benefit

 

 

(740

)

 

 

21,092

 

 

 

(212

)

 

 

19,756

 

Net income

 

 

31,515

 

 

 

56,639

 

 

 

86,506

 

 

 

59,878

 

Net income attributable to noncontrolling interests

 

 

(302

)

 

 

(712

)

 

 

(974

)

 

 

(847

)

Net income attributable to controlling interest

 

$

31,213

 

 

$

55,927

 

 

$

85,532

 

 

$

59,031

 

Net income per common share attributable to controlling
   interest:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.14

 

 

$

0.33

 

 

$

0.43

 

 

$

0.36

 

Diluted

 

$

0.14

 

 

$

0.33

 

 

$

0.43

 

 

$

0.36

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

216,783,990

 

 

 

169,010,301

 

 

 

199,046,304

 

 

 

162,188,510

 

Diluted

 

 

217,711,583

 

 

 

169,802,090

 

 

 

199,494,794

 

 

 

162,908,219

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

31,515

 

 

$

56,639

 

 

$

86,506

 

 

$

59,878

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

8

 

 

 

(121

)

 

 

(101

)

 

 

398

 

Total other comprehensive income (loss)

 

 

8

 

 

 

(121

)

 

 

(101

)

 

 

398

 

Comprehensive income

 

 

31,523

 

 

 

56,518

 

 

 

86,405

 

 

 

60,276

 

Comprehensive income attributable to noncontrolling
   interests

 

 

(302

)

 

 

(712

)

 

 

(974

)

 

 

(847

)

Comprehensive income attributable to controlling interest

 

$

31,221

 

 

$

55,806

 

 

$

85,431

 

 

$

59,429

 

 

 

 

 

 

 

 

 

 

Page | 8


 

AMERICAN HEALTHCARE REIT, INC.

 

NAREIT FFO and Normalized FFO Reconciliation

For the Three and Nine Months Ended September 30, 2026 and 2025

(In thousands, except share and per share amounts) (Unaudited)

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net income

 

$

31,515

 

 

$

56,639

 

 

$

86,506

 

 

$

59,878

 

Depreciation and amortization related to real estate —
   consolidated properties

 

 

90,800

 

 

 

49,115

 

 

 

229,849

 

 

 

131,980

 

Depreciation and amortization related to real estate —
   unconsolidated entities

 

 

43

 

 

 

15

 

 

 

71

 

 

 

1,018

 

Impairment of real estate investments —
   consolidated properties

 

 

—

 

 

 

3,768

 

 

 

2,137

 

 

 

38,133

 

(Gain) loss on dispositions of real estate investments, net —
   consolidated properties

 

 

—

 

 

 

(691

)

 

 

(5,647

)

 

 

2,344

 

Gain on re-measurement of previously held equity interest

 

 

—

 

 

 

(14,580

)

 

 

—

 

 

 

(14,580

)

Net income attributable to noncontrolling interests

 

 

(302

)

 

 

(712

)

 

 

(974

)

 

 

(847

)

Depreciation, amortization, impairments, net gain/loss on
   dispositions and gain on re-measurement —
   noncontrolling interests

 

 

(1,449

)

 

 

(521

)

 

 

(3,005

)

 

 

(2,216

)

NAREIT FFO attributable to controlling interest

 

$

120,607

 

 

$

93,033

 

 

$

308,937

 

 

$

215,710

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction, transition and restructuring costs

 

$

5,113

 

 

$

50

 

 

$

9,870

 

 

$

1,808

 

Amortization of above- and below-market leases

 

 

281

 

 

 

295

 

 

 

911

 

 

 

1,063

 

Amortization of direct origination and closing costs — debt investments

 

 

739

 

 

 

11

 

 

 

763

 

 

 

60

 

Change in deferred rent

 

 

(184

)

 

 

(485

)

 

 

(1,120

)

 

 

(1,877

)

Non-cash impact of changes to equity instruments (1)

 

 

9,284

 

 

 

3,429

 

 

 

19,909

 

 

 

9,170

 

Non-cash income tax benefit

 

 

(294

)

 

 

(21,401

)

 

 

(1,241

)

 

 

(21,401

)

Capitalized interest

 

 

(834

)

 

 

(401

)

 

 

(2,189

)

 

 

(843

)

(Gain) loss on debt extinguishments

 

 

—

 

 

 

(22

)

 

 

147

 

 

 

1,784

 

Loss (gain) in fair value of derivative financial instruments

 

 

106

 

 

 

(166

)

 

 

(1,778

)

 

 

1,213

 

Foreign currency loss (gain)

 

 

619

 

 

 

977

 

 

 

1,363

 

 

 

(3,181

)

Other non-recurring income (2)

 

 

(8,815

)

 

 

—

 

 

 

(8,815

)

 

 

—

 

Adjustments for unconsolidated entities

 

 

(1

)

 

 

(1

)

 

 

(2

)

 

 

4

 

Adjustments for noncontrolling interests

 

 

(62

)

 

 

211

 

 

 

(192

)

 

 

139

 

Normalized FFO attributable to controlling interest

 

$

126,559

 

 

$

75,530

 

 

$

326,563

 

 

$

203,649

 

NAREIT FFO and Normalized FFO weighted average common
   share outstanding — diluted

 

 

217,711,583

 

 

 

169,802,090

 

 

 

199,494,794

 

 

 

162,908,219

 

NAREIT FFO per common share attributable to controlling
   interest — diluted

 

$

0.55

 

 

$

0.54

 

 

$

1.55

 

 

$

1.32

 

Normalized FFO per common share attributable to controlling
   interest — diluted

 

$

0.58

 

 

$

0.44

 

 

$

1.64

 

 

$

1.25

 

 

(1)
For the three and nine months ended September 30, 2026, stock compensation expense includes $4,594,000 related to the accelerated vesting and modification of certain outstanding equity awards in connection with our previously disclosed Chief Executive Officer and Chief Financial Officer transitions during the third quarter of 2026, net of forfeitures.
(2)
Represents certain Ohio Medicaid quality incentive payments received by our ISHC segment pursuant to Ohio House Bill 479, or HB 479, that do not relate to the 2026 rate period. HB 479 was enacted in June 2026 and appropriated funding for nursing facility quality incentive payments. These amounts are included in resident fees and services revenue in our accompanying condensed consolidated statements of operations and comprehensive income, but are not reflective of our on-going operating performance.

Page | 9


 

AMERICAN HEALTHCARE REIT, INC.

 

Adjusted EBITDA Reconciliation

For the Three Months Ended September 30, 2026

(In thousands) (Unaudited)

 

Net income

 

$

31,515

 

Interest expense, net (including amortization of deferred financing costs and amortization of debt
  discount/premium)

 

 

17,773

 

Income tax expense

 

 

740

 

Depreciation and amortization (including amortization of leased assets and accretion of lease liabilities)

 

 

91,403

 

EBITDA

 

 

141,431

 

Income from unconsolidated entities

 

 

(49

)

Straight line rent and amortization of above/below market leases

 

 

(437

)

Non-cash impact of changes to equity instruments

 

 

9,284

 

Transaction, transition and restructuring costs

 

 

5,113

 

Amortization of direct origination and closing costs — debt investments

 

 

739

 

Foreign currency loss

 

 

619

 

Loss in fair value of derivative financial instruments

 

 

106

 

Other non-recurring income

 

 

(8,815

)

Adjusted EBITDA

 

$

147,991

 

 

Page | 10


 

AMERICAN HEALTHCARE REIT, INC.

 

NOI and Cash NOI Reconciliation

For the Three and Nine Months Ended September 30, 2026 and 2025

(In thousands) (Unaudited)

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net income

 

 

31,515

 

 

 

56,639

 

 

 

86,506

 

 

 

59,878

 

General and administrative

 

 

21,582

 

 

 

14,108

 

 

 

59,078

 

 

 

42,206

 

Transaction, transition and restructuring costs

 

 

5,113

 

 

 

50

 

 

 

9,870

 

 

 

1,808

 

Depreciation and amortization

 

 

90,869

 

 

 

49,181

 

 

 

230,056

 

 

 

132,236

 

Interest expense, net

 

 

17,773

 

 

 

20,392

 

 

 

55,195

 

 

 

65,969

 

Loss (gain) in fair value of derivative financial instruments

 

 

106

 

 

 

(166

)

 

 

(1,778

)

 

 

1,213

 

(Gain) loss on dispositions of real estate investments, net

 

 

—

 

 

 

(691

)

 

 

(5,647

)

 

 

2,344

 

Impairment of real estate investments

 

 

—

 

 

 

3,768

 

 

 

2,137

 

 

 

38,133

 

(Income) loss from unconsolidated entities

 

 

(49

)

 

 

(462

)

 

 

(1,733

)

 

 

2,624

 

Gain on re-measurement of previously held equity interest

 

 

—

 

 

 

(14,580

)

 

 

—

 

 

 

(14,580

)

Foreign currency loss (gain)

 

 

619

 

 

 

977

 

 

 

1,363

 

 

 

(3,181

)

Other income, net

 

 

(3,473

)

 

 

(2,309

)

 

 

(7,722

)

 

 

(5,314

)

Income tax expense (benefit)

 

 

740

 

 

 

(21,092

)

 

 

212

 

 

 

(19,756

)

Net operating income

 

 

164,795

 

 

 

105,815

 

 

 

427,537

 

 

 

303,580

 

Straight line rent

 

 

(297

)

 

 

(730

)

 

 

(1,580

)

 

 

(2,286

)

Facility rental expense

 

 

6,752

 

 

 

7,030

 

 

 

20,265

 

 

 

21,807

 

Other non-cash adjustments

 

 

934

 

 

 

133

 

 

 

1,025

 

 

 

517

 

Cash NOI from dispositions

 

 

(6

)

 

 

(102

)

 

 

(351

)

 

 

(716

)

Cash NOI attributable to noncontrolling interests (1)

 

 

(734

)

 

 

(251

)

 

 

(1,234

)

 

 

(758

)

Cash NOI (1)

 

$

171,444

 

 

$

111,895

 

 

$

445,662

 

 

$

322,144

 

 

 

(1)
All periods are based upon current quarter's ownership percentage.

 

Page | 11


 

AMERICAN HEALTHCARE REIT, INC.

 

Same-Store Revenue Reconciliation

For the Three and Nine Months Ended September 30, 2026 and 2025

(In thousands) (Unaudited)

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

ISHC

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Revenue

 

$

534,189

 

 

$

455,452

 

 

$

1,549,810

 

 

$

1,313,494

 

Cash revenue from dispositions

 

 

—

 

 

 

1

 

 

 

(2,069

)

 

 

(2,680

)

Cash revenue

 

 

534,189

 

 

 

455,453

 

 

 

1,547,741

 

 

 

1,310,814

 

Revenue attributable to new acquisitions/dispositions/other

 

 

(177,351

)

 

 

(118,985

)

 

 

(507,174

)

 

 

(330,145

)

Revenue attributable to Non-Core Properties

 

 

(3,576

)

 

 

(6,655

)

 

 

(13,698

)

 

 

(19,258

)

Other normalizing revenue adjustments

 

 

(7,772

)

 

 

—

 

 

 

(7,772

)

 

 

—

 

Same-Store revenue

 

$

345,490

 

 

$

329,813

 

 

$

1,019,097

 

 

$

961,411

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SHOP

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Revenue

 

$

166,904

 

 

$

76,606

 

 

$

395,569

 

 

$

217,025

 

Cash revenue from dispositions

 

 

—

 

 

 

(1

)

 

 

—

 

 

 

(167

)

Cash revenue attributable to noncontrolling interests (1)

 

 

(1,929

)

 

 

(278

)

 

 

(2,496

)

 

 

(824

)

Cash revenue (1)

 

 

164,975

 

 

 

76,327

 

 

 

393,073

 

 

 

216,034

 

Revenue attributable to new acquisitions/dispositions

 

 

(88,418

)

 

 

(6,208

)

 

 

(169,892

)

 

 

(9,617

)

Revenue attributable to development conversion

 

 

(1,105

)

 

 

(864

)

 

 

(3,023

)

 

 

(2,255

)

Revenue attributable to Non-Core Properties

 

 

(599

)

 

 

(580

)

 

 

(1,811

)

 

 

(1,749

)

Same-Store revenue (1)

 

$

74,853

 

 

$

68,675

 

 

$

218,347

 

 

$

202,413

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outpatient Medical

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Revenue

 

$

30,666

 

 

$

31,181

 

 

$

91,493

 

 

$

95,629

 

Straight line rent

 

 

24

 

 

 

(243

)

 

 

(434

)

 

 

(675

)

Other non-cash adjustments

 

 

(343

)

 

 

(380

)

 

 

(1,223

)

 

 

(1,054

)

Cash revenue from dispositions

 

 

1

 

 

 

(427

)

 

 

—

 

 

 

(887

)

Cash revenue

 

 

30,348

 

 

 

30,131

 

 

 

89,836

 

 

 

93,013

 

Revenue attributable to dispositions

 

 

—

 

 

 

(154

)

 

 

—

 

 

 

(4,044

)

Revenue attributable to Non-Core Properties

 

 

(1,838

)

 

 

(2,230

)

 

 

(5,485

)

 

 

(7,157

)

Same-Store revenue

 

$

28,510

 

 

$

27,747

 

 

$

84,351

 

 

$

81,812

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Triple-Net Leased Properties

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Revenue

 

$

10,390

 

 

$

9,698

 

 

$

30,301

 

 

$

29,895

 

Straight line rent

 

 

(321

)

 

 

(487

)

 

 

(1,146

)

 

 

(1,611

)

Other non-cash adjustments

 

 

881

 

 

 

200

 

 

 

1,250

 

 

 

624

 

Cash revenue from dispositions

 

 

—

 

 

 

(25

)

 

 

(27

)

 

 

(25

)

Cash revenue attributable to noncontrolling interest (1)

 

 

(198

)

 

 

(194

)

 

 

(587

)

 

 

(575

)

Cash revenue (1)

 

 

10,752

 

 

 

9,192

 

 

 

29,791

 

 

 

28,308

 

Debt investments (2)

 

 

(2,771

)

 

 

(1,165

)

 

 

(5,100

)

 

 

(3,809

)

Revenue attributable to dispositions

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(52

)

Revenue attributable to Non-Core Properties

 

 

—

 

 

 

(157

)

 

 

(159

)

 

 

(470

)

Other normalizing revenue adjustments

 

 

—

 

 

 

—

 

 

 

(354

)

 

 

(522

)

Same-Store revenue (1)

 

$

7,981

 

 

$

7,870

 

 

$

24,178

 

 

$

23,455

 

 

 

Page | 12


 

AMERICAN HEALTHCARE REIT, INC.

 

Same-Store Revenue Reconciliation - (Continued)

For the Three and Nine Months Ended September 30, 2026 and 2025

(In thousands) (Unaudited)

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Total Portfolio

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Revenue

 

$

742,149

 

 

$

572,937

 

 

$

2,067,173

 

 

$

1,656,043

 

Straight line rent

 

 

(297

)

 

 

(730

)

 

 

(1,580

)

 

 

(2,286

)

Other non-cash adjustments

 

 

538

 

 

 

(180

)

 

 

27

 

 

 

(430

)

Cash revenue from dispositions

 

 

1

 

 

 

(452

)

 

 

(2,096

)

 

 

(3,759

)

Cash revenue attributable to noncontrolling interests (1)

 

 

(2,127

)

 

 

(472

)

 

 

(3,083

)

 

 

(1,399

)

Cash revenue (1)

 

 

740,264

 

 

 

571,103

 

 

 

2,060,441

 

 

 

1,648,169

 

Debt investments (2)

 

 

(2,771

)

 

 

(1,165

)

 

 

(5,100

)

 

 

(3,809

)

Revenue attributable to new acquisitions/dispositions/other

 

 

(265,769

)

 

 

(125,347

)

 

 

(677,066

)

 

 

(343,858

)

Revenue attributable to development conversion

 

 

(1,105

)

 

 

(864

)

 

 

(3,023

)

 

 

(2,255

)

Revenue attributable to Non-Core Properties

 

 

(6,013

)

 

 

(9,622

)

 

 

(21,153

)

 

 

(28,634

)

Other normalizing revenue adjustments

 

 

(7,772

)

 

 

—

 

 

 

(8,126

)

 

 

(522

)

Same-Store revenue (1)

 

$

456,834

 

 

$

434,105

 

 

$

1,345,973

 

 

$

1,269,091

 

 

 

(1)
All periods are based upon current quarter's ownership percentage.
(2)
Relates to debt security investment and debt investment within Triple-Net Leased Properties.

 

Page | 13


 

AMERICAN HEALTHCARE REIT, INC.

 

Same-Store NOI Reconciliation

For the Three and Nine Months Ended September 30, 2026 and 2025

(In thousands) (Unaudited)

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

ISHC

 

 

 

 

 

 

 

 

 

 

 

 

NOI

 

$

90,047

 

 

$

62,168

 

 

$

239,965

 

 

$

176,093

 

Facility rental expense

 

 

6,752

 

 

 

7,030

 

 

 

20,265

 

 

 

21,807

 

Cash NOI from dispositions

 

 

—

 

 

 

1

 

 

 

(328

)

 

 

(472

)

Cash NOI

 

 

96,799

 

 

 

69,199

 

 

 

259,902

 

 

 

197,428

 

New acquisitions/dispositions/other

 

 

(16,039

)

 

 

(6,538

)

 

 

(38,699

)

 

 

(12,464

)

Non-Core Properties

 

 

(510

)

 

 

(1,078

)

 

 

(1,928

)

 

 

(2,822

)

Other normalizing adjustments

 

 

(7,772

)

 

 

1,044

 

 

 

(7,772

)

 

 

1,044

 

Same-Store NOI

 

$

72,478

 

 

$

62,627

 

 

$

211,503

 

 

$

183,186

 

 

 

 

 

 

 

 

 

 

 

 

 

SHOP

 

 

 

 

 

 

 

 

 

 

 

 

NOI

 

$

46,209

 

 

$

15,360

 

 

$

103,568

 

 

$

41,188

 

Other non-cash adjustments

 

 

102

 

 

 

—

 

 

 

102

 

 

 

—

 

Cash NOI from dispositions

 

 

—

 

 

 

24

 

 

 

—

 

 

 

88

 

Cash NOI attributable to noncontrolling interests (1)

 

 

(536

)

 

 

(58

)

 

 

(648

)

 

 

(185

)

Cash NOI (1)

 

 

45,775

 

 

 

15,326

 

 

 

103,022

 

 

 

41,091

 

New acquisitions/dispositions

 

 

(28,092

)

 

 

(1,921

)

 

 

(54,829

)

 

 

(2,771

)

Development conversion

 

 

(104

)

 

 

343

 

 

 

207

 

 

 

980

 

Non-Core Properties

 

 

(24

)

 

 

(59

)

 

 

(122

)

 

 

(176

)

Other normalizing adjustments

 

 

—

 

 

 

—

 

 

 

—

 

 

 

147

 

Same-Store NOI (1)

 

$

17,555

 

 

$

13,689

 

 

$

48,278

 

 

$

39,271

 

 

 

 

 

 

 

 

 

 

 

 

 

Outpatient Medical

 

 

 

 

 

 

 

 

 

 

 

 

NOI

 

$

18,573

 

 

$

19,128

 

 

$

55,783

 

 

$

58,699

 

Straight line rent

 

 

24

 

 

 

(243

)

 

 

(434

)

 

 

(675

)

Other non-cash adjustments

 

 

(68

)

 

 

(85

)

 

 

(382

)

 

 

(162

)

Cash NOI from dispositions

 

 

(6

)

 

 

(127

)

 

 

4

 

 

 

(332

)

Cash NOI

 

 

18,523

 

 

 

18,673

 

 

 

54,971

 

 

 

57,530

 

Dispositions

 

 

—

 

 

 

83

 

 

 

—

 

 

 

(1,763

)

Non-Core Properties

 

 

(956

)

 

 

(1,259

)

 

 

(2,764

)

 

 

(4,183

)

Same-Store NOI

 

$

17,567

 

 

$

17,497

 

 

$

52,207

 

 

$

51,584

 

 

 

 

 

 

 

 

 

 

 

 

 

Triple-Net Leased Properties

 

 

 

 

 

 

 

 

 

 

 

 

NOI

 

$

9,966

 

 

$

9,159

 

 

$

28,221

 

 

$

27,600

 

Straight line rent

 

 

(321

)

 

 

(487

)

 

 

(1,146

)

 

 

(1,611

)

Other non-cash adjustments

 

 

900

 

 

 

218

 

 

 

1,305

 

 

 

679

 

Cash NOI from dispositions

 

 

—

 

 

 

—

 

 

 

(27

)

 

 

—

 

Cash NOI attributable to noncontrolling interest (1)

 

 

(198

)

 

 

(193

)

 

 

(586

)

 

 

(573

)

Cash NOI (1)

 

 

10,347

 

 

 

8,697

 

 

 

27,767

 

 

 

26,095

 

Debt investments (2)

 

 

(2,771

)

 

 

(1,165

)

 

 

(5,100

)

 

 

(3,809

)

Dispositions

 

 

—

 

 

 

—

 

 

 

—

 

 

 

3

 

Non-Core Properties

 

 

—

 

 

 

(157

)

 

 

(159

)

 

 

(464

)

Same-Store NOI (1)

 

$

7,576

 

 

$

7,375

 

 

$

22,508

 

 

$

21,825

 

 

 

Page | 14


 

AMERICAN HEALTHCARE REIT, INC.

 

Same-Store NOI Reconciliation - (Continued)

For the Three and Nine Months Ended September 30, 2026 and 2025

(In thousands) (Unaudited)

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Total Portfolio

 

 

 

 

 

 

 

 

 

 

 

 

NOI

 

$

164,795

 

 

$

105,815

 

 

$

427,537

 

 

$

303,580

 

Straight line rent

 

 

(297

)

 

 

(730

)

 

 

(1,580

)

 

 

(2,286

)

Facility rental expense

 

 

6,752

 

 

 

7,030

 

 

 

20,265

 

 

 

21,807

 

Other non-cash adjustments

 

 

934

 

 

 

133

 

 

 

1,025

 

 

 

517

 

Cash NOI from dispositions

 

 

(6

)

 

 

(102

)

 

 

(351

)

 

 

(716

)

Cash NOI attributable to noncontrolling interests (1)

 

 

(734

)

 

 

(251

)

 

 

(1,234

)

 

 

(758

)

Cash NOI (1)

 

 

171,444

 

 

 

111,895

 

 

 

445,662

 

 

 

322,144

 

Debt investments (2)

 

 

(2,771

)

 

 

(1,165

)

 

 

(5,100

)

 

 

(3,809

)

New acquisitions/dispositions/other

 

 

(44,131

)

 

 

(8,376

)

 

 

(93,528

)

 

 

(16,995

)

Development conversion

 

 

(104

)

 

 

343

 

 

 

207

 

 

 

980

 

Non-Core Properties

 

 

(1,490

)

 

 

(2,553

)

 

 

(4,973

)

 

 

(7,645

)

Other normalizing adjustments

 

 

(7,772

)

 

 

1,044

 

 

 

(7,772

)

 

 

1,191

 

Same-Store NOI (1)

 

$

115,176

 

 

$

101,188

 

 

$

334,496

 

 

$

295,866

 

 

 

(1)
All periods are based upon current quarter's ownership percentage.
(2)
Relates to debt security investment and debt investment within Triple-Net Leased Properties.

 

Page | 15


 

AMERICAN HEALTHCARE REIT, INC.

 

Earnings Guidance Reconciliation

For the Year Ending December 31, 2026

(Dollars and shares in millions, except per share amounts) (Unaudited)

 

 

Full Year
2026 Guidance

 

Prior Full Year
2026 Guidance

 

Low

 

High

 

Low

 

High

Net income attributable to common stockholders

 

$123.2

 

$129.2

 

$108.5

 

$116.5

Depreciation and amortization (1)

 

322.1

 

322.1

 

306.8

 

306.8

Impairment and gains/losses from dispositions (1)

 

(3.5)

 

(3.5)

 

(3.9)

 

(3.9)

NAREIT FFO attributable to common stockholders

 

$441.8

 

$447.8

 

$411.4

 

$419.4

Amortization of other intangible assets/liabilities (1)

 

2.7

 

2.7

 

1.3

 

1.3

Change in deferred rent (1)

 

(1.3)

 

(1.3)

 

(1.6)

 

(1.6)

Non-cash impact of changes to equity plan (1) (2)

 

26.3

 

26.3

 

21.9

 

21.9

Other adjustments (1) (3)

 

(6.2)

 

(6.2)

 

(0.2)

 

(0.2)

Normalized FFO attributable to common stockholders

 

$463.3

 

$469.3

 

$432.8

 

$440.8

 

 

 

 

 

 

 

 

 

Net income per common share — diluted

 

$0.59

 

$0.62

 

$0.54

 

$0.58

NAREIT FFO per common share — diluted

 

$2.13

 

$2.16

 

$2.04

 

$2.08

Normalized FFO per common share — diluted

 

$2.23

 

$2.26

 

$2.15

 

$2.19

NAREIT FFO and Normalized FFO weighted average
      shares — diluted

 

207.7

 

207.7

 

201.3

 

201.3

 

 

 

 

 

 

 

 

 

Total Portfolio Same-Store NOI growth

 

12.0%

 

14.0%

 

11.0%

 

13.0%

Segment-Level Same-Store NOI growth:

 

 

 

 

 

 

 

 

ISHC

 

14.5%

 

16.5%

 

13.0%

 

16.0%

SHOP

 

23.0%

 

26.0%

 

18.0%

 

21.0%

Outpatient Medical

 

0.5%

 

1.0%

 

0.0%

 

1.0%

Triple-Net Leased Properties

 

2.5%

 

3.5%

 

2.0%

 

3.0%

 

(1)
Amounts presented net of noncontrolling interests' share and AHR's share of unconsolidated entities.
(2)
Amounts represent amortization of equity compensation and fair value adjustments to performance-based equity compensation.
(3)
Includes adjustments for capitalized interest, transaction, transition and restructuring costs, and additional items as noted in the Company’s definition of Normalized FFO.

Page | 16


 

Definitions

 

•
Adjusted EBITDA: EBITDA excluding the impact of income or loss from unconsolidated entities, straight line rent and amortization of above/below market leases, non-cash impact of changes to equity instruments, transaction, transition and restructuring costs, gain or loss on dispositions of real estate investments, amortization of direct origination and closing costs on debt investments, unrealized foreign currency gain or loss, change in fair value of derivative financial instruments, impairments of real estate investments, impairments of intangible assets and goodwill, and non-recurring and/or one-time items.
•
Annualized Adjusted EBITDA: Current period (shown as quarterly) Adjusted EBITDA multiplied by 4.
•
ATM Program: At-the-market equity offering program.
•
Cash NOI: NOI excluding the impact of, without duplication, (1) non-cash items such as straight-line rent and the amortization of lease intangibles, (2) third-party facility rent payments and (3) other items set forth in the Cash NOI reconciliation included herein. Both Cash NOI and Same-Store NOI include Pro-Rata ownership and other adjustments.
•
EBITDA: A non-GAAP financial measure that is defined as earnings before interest, taxes, depreciation and amortization.
•
GAAP Revenue: Revenue recognized in accordance with Generally Accepted Accounting Principles (“GAAP”), which includes straight line rent and other non-cash adjustments.
•
ISHC: Integrated senior health campuses include a range of senior care, including independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. Integrated senior health campuses are operated utilizing a RIDEA structure.
•
NAREIT FFO or FFO: Funds from operations attributable to controlling interest; a non-GAAP financial measure, consistent with the standards established by the White Paper on FFO approved by the Board of Governors of NAREIT (the “White Paper”). The White Paper defines FFO as net income (loss) computed in accordance with GAAP, excluding gains or losses from dispositions of certain real estate assets, gains or losses upon consolidation of a previously held equity interest, and impairment write-downs of certain real estate assets and investments, plus depreciation and amortization related to real estate, after adjustments for unconsolidated partnerships and joint ventures. While impairment charges are excluded from the calculation of FFO as described above, investors are cautioned that impairments are based on estimated future undiscounted cash flows. Adjustments for unconsolidated partnerships and joint ventures are calculated to reflect FFO.
•
Net Debt: Total Debt, excluding operating lease liabilities, less cash and cash equivalents and restricted cash related to debt. For a reconciliation of Net Debt to total debt, refer to the Company’s Third Quarter 2026 Supplemental Financial Information.
•
NOI: Net operating income; a non-GAAP financial measure that is defined as net income (loss), computed in accordance with GAAP, generated from properties before general and administrative expenses, transaction, transition and restructuring costs, depreciation and amortization, interest expense, gain or loss in fair value of derivative financial instruments, gain or loss on dispositions of real estate investments, impairment of real estate investments, impairment of intangible assets and goodwill, income or loss from unconsolidated entities, gain on re-measurement of previously held equity interest, foreign currency gain or loss, other income or expense and income tax benefit or expense.
•
Non-Core Properties: Assets that have been deemed not essential to generating future economic benefit or value to our day-to-day operations and/or are projected to be sold.
•
Normalized FFO or NFFO: FFO further adjusted for the following items included in the determination of GAAP net income (loss): transaction, transition and restructuring costs; amounts relating to changes in deferred rent and amortization of above- and below-market leases (which are adjusted in order to reflect such payments from a GAAP accrual basis); the non-cash impact of changes to our equity instruments; non-cash or non-recurring income or expense; the non-cash effect of income tax benefits or expenses; capitalized interest; impairment of intangible assets and goodwill; amortization of direct origination and closing costs on debt investments; mark-to-market adjustments included in net income (loss); gains or losses included in net income (loss) from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or securities holdings where trading of such holdings is not a fundamental attribute of the business plan; and after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect Normalized FFO on the same basis.
•
Occupancy: With respect to OM, the percentage of total rentable square feet leased and occupied, including month-to-month leases, as of the date reported. With respect to all other property types, occupancy represents average quarterly operating occupancy based on the most recent quarter of available data. The Company uses unaudited, periodic financial information provided solely by tenants to calculate occupancy and has not independently verified the information.
•
Outpatient Medical or OM: Outpatient Medical properties.
•
Pro-Rata: As of September 30, 2026, we owned and/or operated buildings/properties through entities of which we owned less than 100% of the ownership interests. Because we have a controlling interest in these entities, these entities and the properties these entities own are consolidated in our financial statements in accordance with GAAP. However, while such properties are presented in our financial statements on a consolidated basis, we are only entitled to our Pro-Rata share of the net cash flows generated by such properties. As a result, we have presented certain property information herein based on our Pro-Rata ownership interest in these entities and the properties these entities own, as of the applicable date, and not on a consolidated basis. In such instances, information is noted as being presented on a “Pro-Rata share” basis.

 

Page | 17


 

•
RIDEA structure: A structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, pursuant to which we lease certain healthcare real estate properties to a wholly-owned taxable REIT subsidiary (“TRS”), which in turn contracts with an eligible independent contractor (“EIK”) to operate such properties for a fee. Under this structure, the EIK receives management fees, and the TRS receives revenue from the operation of the healthcare real estate properties and retains, as profit, any revenue remaining after payment of expenses (including intercompany rent paid to us and any taxes at the TRS level) necessary to operate the property. Through the RIDEA structure, in addition to receiving rental revenue from the TRS, we retain any after-tax profit from the operation of the healthcare real estate properties and benefit from any improved operational performance while bearing the risk of any decline in operating performance at the properties.
•
Same-Store or SS: Properties owned or consolidated the full year in both comparison years and that are not otherwise excluded. Properties are excluded from Same-Store if they are: (1) sold, classified as held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (2) impacted by materially disruptive events, such as flood or fire for an extensive period of time; or (3) scheduled to undergo or currently undergoing major expansions/renovations or business model transitions or have transitioned business models after the start of the prior comparison period.
•
Same-Store NOI or SS NOI: Cash NOI for our Same-Store properties. Same-Store NOI is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. Both Cash NOI and Same-Store NOI include ownership and other adjustments.
•
SHOP: Senior housing operating properties.
•
Total Debt: The principal balances of the Company’s revolving credit facilities, term loan and secured indebtedness as reported in the Company’s consolidated financial statements.
•
Trilogy: Trilogy Investors, LLC; one of our consolidated subsidiaries, in which we indirectly own a 100% interest as of September 30, 2026.
•
Trilogy Management Services: Trilogy Management Services, LLC, an independent third-party operator that qualifies as an eligible independent contractor and manages all of the Company's integrated senior health campuses.
•
Triple-Net Leased: A lease where the tenant is responsible for making rent payments, maintaining the leased property, and paying property taxes and other expenses.

Page | 18


img33188571_0.jpg

Third Quarter 2026 Supplemental

Exhibit 99.2

The Lodge at Historic Lewes

Lewes, DE

 

 


 

 

Disclaimers

img33188571_1.jpg

Forward-Looking Statements

 

Certain statements contained in this supplemental, furnished in conjunction with the Third Quarter 2026 Earnings Press Release, including statements relating to American Healthcare REIT, Inc.'s (the "Company") expectations regarding its performance, interest expense, balance sheet, full year 2026 guidance and the assumptions therein, including net income or loss attributable to common stockholders and per diluted share, NAREIT FFO attributable to common stockholders and per diluted share, NFFO attributable to common stockholders and per diluted share, NOI growth, total portfolio Same-Store NOI growth, segment-level Same-Store NOI growth, Occupancy, revenue growth, purchases, sales, and development of assets, may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends for all such forward-looking statements to be covered by the applicable safe harbor provisions for forward-looking statements contained in those acts. Such forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “can,” “expect,” “intend,” “anticipate,” “estimate,” “believe,” “continue,” “possible,” “initiatives,” “focus,” “seek,” “objective,” “goal,” “strategy,” “plan,” “potential,” “potentially,” “preparing,” “projected,” “future,” “long-term,” “once,” “should,” “could,” “would,” “might,” “uncertainty,” or other similar words. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this supplemental. Any such forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which the Company operates and beliefs of, and assumptions made by, the Company's management and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied therein, including, without limitation, changing macroeconomic, domestic legal and fiscal policies; geopolitical conditions and other risks disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 27, 2026, and other periodic reports as filed with the Securities and Exchange Commission. Except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statement.

 

Non-GAAP Financial Measures

 

The Company’s reported results are presented in accordance with generally accepted accounting principles in the United States ("GAAP"). The Company also discloses the following non-GAAP financial measures: EBITDA, Adjusted EBITDA, Net Debt-to-Annualized Adjusted EBITDA, NAREIT FFO, NFFO, NOI, Same-Store NOI, Cash NOI, Pro-Rata Cash NOI, Annualized Cash NOI, Interest Coverage Ratio, Fixed Charge Coverage Ratio and constant currency Same-Store NOI. The Company believes these non-GAAP financial measures are useful supplemental measures of its operating performance and are used by investors and analysts to compare the operating performance of the Company between periods and to other real estate investment trusts ("REITs") or companies on a consistent basis without having to account for differences caused by unanticipated and/or incalculable items. Definitions of the non-GAAP financial measures used herein and reconciliations to the most directly comparable financial measure calculated in accordance with GAAP can be found at the end of this supplemental. See below and the appendix for further information regarding the Company's non-GAAP financial measures.

 

EBITDA and Adjusted EBITDA

 

Management uses earnings before interest, taxes, depreciation and amortization (“EBITDA”) and Adjusted EBITDA to facilitate internal and external comparisons to our historical operating results and in making operating decisions. EBITDA and Adjusted EBITDA are widely used by investors, lenders, credit and equity analysts in the valuation, comparison, and investment recommendations of companies. Additionally, EBITDA and Adjusted EBITDA are utilized by our Board of Directors to evaluate management. Neither EBITDA nor Adjusted EBITDA represents net income (loss) or cash flows provided by operating activities as determined in accordance with GAAP and should not be considered as alternative measures of profitability or liquidity. In addition, management uses Net Debt-to-Annualized Adjusted EBITDA as a measure of our ability to service our debt. Finally, EBITDA and Adjusted EBITDA may not be comparable to similarly titled items reported by other REITs or other companies.

 

NAREIT Funds from Operations (FFO) and Normalized Funds from Operations (NFFO)

 

We believe that the use of FFO, which excludes the impact of real estate-related depreciation and amortization and impairments, provides a further understanding of our operating performance to investors, industry analysts and our management, and when compared year over year, reflects the impact on our operations from trends in Occupancy rates, rental rates, operating costs, general and administrative expenses and interest costs, which may not be immediately apparent from net income (loss) as determined in accordance with GAAP. However, FFO and NFFO should not be construed to be (i) more relevant or accurate than the current GAAP methodology in calculating net income (loss) as an indicator of our operating performance, (ii) more relevant or accurate than GAAP cash flows from operations as an indicator of our liquidity or (iii) indicative of funds available to fund our cash needs, including our ability to make distributions to our stockholders. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the non-GAAP FFO and NFFO measures and the adjustments to GAAP in calculating FFO and NFFO. Presentation of this information is intended to provide useful information to investors, industry analysts and management as they compare the operating performance metrics used by the REIT industry, although it should be noted that some REITs may use different methods of calculating funds from operations and normalized funds from operations, so comparisons with such REITs may not be meaningful.

 

Net Operating Income (NOI)

 

We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are appropriate supplemental performance measures to reflect the performance of our operating assets because NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI exclude certain items that are not associated with the operations of the properties. We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are widely accepted measures of comparative operating performance in the real estate community and are useful to investors in understanding the profitability and operating performance of our property portfolio. However, our use of the terms NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are not equivalent to our net income (loss) as determined under GAAP and may not be a useful measure of operational income or cash flows. Furthermore, NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be considered as alternatives to net income (loss) as an indication of our operating performance or as an alternative to cash flows from operations as an indication of our liquidity. NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be construed to be more relevant or accurate than the GAAP methodology in calculating net income (loss). NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should be reviewed in conjunction with other measurements as an indication of our performance.

American Healthcare REIT | Q3 2026 Supplemental | Page 2


Pro-Rata Annualized Cash NOI

img33188571_2.jpg

 

 

Overview (as of September 30, 2026)

img33188571_1.jpg

(dollars in thousands, except per share and Pro-Rata)

Portfolio Overview

 

 

 

 

 

 

 

 

 

 

 

 

 

Campuses/
Properties

 

Beds/
Units
 (1)

 

Leased % (2)

 

WALT
(years)

 

Annualized
Cash NOI
(3)

 

 

Integrated Senior Health Campuses (ISHC)

 

149

 

15,105

 

90.5%

 

—

 

$387,196

 

56.5%

Senior Housing Operating Properties (SHOP)

 

109

 

10,072

 

90.1%

 

—

 

183,100

 

26.7%

Outpatient Medical (OM)

 

70

 

3,654

 

87.7%

 

4.9

 

74,092

 

10.8%

Triple-Net Leased Properties

 

17

 

1,364

 

89.8%

 

12.1

 

30,304

 

4.4%

Debt Investments (4)

 

—

 

—

 

—

 

—

 

11,084

 

1.6%

Total

 

345

 

 

 

 

 

6.5

 

$685,776

 

100.0%

Same-Store NOI Performance (3)

 

Campuses /
Properties

 

Q3 2025

 

Q3 2026

 

%
Change

 

YTD
9/30/25

 

YTD
9/30/26

 

%
Change

ISHC

 

115

 

$62,627

 

$72,478

 

15.7%

 

$183,186

 

$211,503

 

15.5%

SHOP

 

64

 

13,689

 

17,555

 

28.2%

 

39,271

 

48,278

 

22.9%

OM

 

65

 

17,497

 

17,567

 

0.4%

 

51,584

 

52,207

 

1.2%

Triple-Net Leased Properties

 

17

 

7,375

 

7,576

 

2.7%

 

21,825

 

22,508

 

3.1%

Total

 

261

 

$101,188

 

$115,176

 

13.8%

 

$295,866

 

$334,496

 

13.1%

 

Earnings Metrics (3)

Q3 2025

 

Q3 2026

 

%
Change

 

YTD
9/30/2025

 

YTD
9/30/2026

 

%
Change

NAREIT FFO per share - diluted

$0.54

 

$0.55

 

1.9%

 

$1.32

 

$1.55

 

17.4%

Normalized FFO per share - diluted

$0.44

 

$0.58

 

31.8%

 

$1.25

 

$1.64

 

31.2%

 

Balance Sheet Metrics

 

 

Coverage

Interest Coverage Ratio

8.7X

 

 

Fixed Charge Coverage Ratio

6.8X

 

 

Net Debt-to-Annualized Adjusted EBITDA

1.9X

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

OM presents GLA in thousands, rather than Beds/Units.

(2)

Occupancy for ISHC, SHOP, and Triple-Net Leased Properties is reported as a quarterly average, while OM Occupancy is reported on a quarter-end spot basis. Triple-Net Leased Properties exclude Hospitals.

(3)

See reconciliations in the appendix of this supplemental. Annualized Cash NOI shown as current quarter Cash NOI multiplied by four.

(4)

Relates to debt security investment and debt investment within Triple-Net Leased Properties.

 

 

 

Note: Except as otherwise noted, all data herein is presented on a consolidated basis. The contents of this Supplemental are unaudited and totals may not add due to rounding.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 3


 

Integrated Senior Health Campuses

img33188571_3.jpg

(dollars in thousands)

Total Portfolio

 

 

Q3 2025

 

Q4 2025

 

Q1 2026

 

Q2 2026

 

Q3 2026

 

 

 

 

YTD 9/30/25

 

YTD
9/30/26

 

 

Campuses

 

135

 

149

 

149

 

148

 

149

 

 

 

 

—

 

—

 

 

IL units

 

1,304

 

1,436

 

1,488

 

1,531

 

1,559

 

 

 

 

1,304

 

1,559

 

 

AL/MC units

 

4,850

 

5,454

 

5,459

 

5,429

 

5,427

 

 

 

 

4,850

 

5,427

 

 

SNF beds

 

7,601

 

8,275

 

8,275

 

8,137

 

8,119

 

 

 

 

7,601

 

8,119

 

 

Consolidated total beds/units

 

13,755

 

15,165

 

15,222

 

15,097

 

15,105

 

 

 

 

13,755

 

15,105

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total average Occupancy

 

89.6%

 

90.1%

 

89.9%

 

89.5%

 

90.5%

 

 

 

 

89.0%

 

90.0%

 

 

IL/AL/MC average Occupancy

 

91.4%

 

91.9%

 

90.4%

 

90.5%

 

91.0%

 

 

 

 

89.5%

 

90.6%

 

 

SNF average Occupancy

 

88.2%

 

88.7%

 

89.4%

 

88.6%

 

90.1%

 

 

 

 

88.6%

 

89.4%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash revenue (1)

 

$455,453

 

$472,577

 

$502,743

 

$510,809

 

$534,189

 

 

 

 

$1,310,814

 

$1,547,741

 

 

Operating expenses

 

386,254

 

401,798

 

424,223

 

426,226

 

437,390

 

 

 

 

1,113,386

 

1,287,839

 

 

Cash NOI (1)

 

$69,199

 

$70,779

 

$78,520

 

$84,583

 

$96,799

 

 

 

 

$197,428

 

$259,902

 

 

Cash NOI Margin %

 

15.2%

 

15.0%

 

15.6%

 

16.6%

 

18.1%

 

 

 

 

15.1%

 

16.8%

 

 

Maintenance Capex

 

$4,863

 

$5,026

 

$4,657

 

$5,606

 

$7,668

 

 

 

 

$12,683

 

$17,931

 

 

Same-Store

 

 

Q3 2025

 

Q4 2025

 

Q1 2026

 

Q2 2026

 

Q3 2026

 

Q3 2026
vs
Q3 2025

 

 

YTD 9/30/25

 

YTD
9/30/26

 

YTD 2026
vs
YTD 2025

Campuses

 

115

 

115

 

115

 

115

 

115

 

 

 

 

115

 

115

 

 

Consolidated beds/units

 

11,711

 

11,708

 

11,710

 

11,721

 

11,708

 

 

 

 

11,711

 

11,708

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total average Occupancy

 

90.1%

 

90.5%

 

91.2%

 

90.7%

 

91.2%

 

111 bps

 

 

89.3%

 

91.0%

 

170 bps

IL/AL/MC average Occupancy

 

91.7%

 

92.0%

 

91.9%

 

91.9%

 

92.6%

 

87 bps

 

 

90.1%

 

92.1%

 

205 bps

SNF average Occupancy

 

88.9%

 

89.3%

 

90.6%

 

89.9%

 

90.2%

 

129 bps

 

 

88.8%

 

90.2%

 

144 bps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Same-Store revenue (1)

 

$329,813

 

$333,382

 

$336,108

 

$337,499

 

$345,490

 

4.8%

 

 

$961,411

 

$1,019,097

 

6.0%

Same-Store operating expenses

 

267,186

 

269,466

 

268,433

 

266,149

 

273,012

 

2.2%

 

 

778,225

 

807,594

 

3.8%

Compensation

 

168,737

 

174,823

 

170,418

 

172,096

 

177,483

 

5.2%

 

 

491,156

 

519,997

 

5.9%

Controllable (2)

 

88,503

 

87,008

 

88,210

 

84,131

 

85,260

 

(3.7%)

 

 

256,529

 

257,601

 

0.4%

Non-Controllable (3)

 

9,946

 

7,635

 

9,805

 

9,922

 

10,269

 

3.2%

 

 

30,540

 

29,996

 

(1.8%)

Same-Store NOI (1)

 

$62,627

 

$63,916

 

$67,675

 

$71,350

 

$72,478

 

15.7%

 

 

$183,186

 

$211,503

 

15.5%

Same-Store NOI Margin %

 

19.0%

 

19.2%

 

20.1%

 

21.1%

 

21.0%

 

199 bps

 

 

19.1%

 

20.8%

 

170 bps

 

 

 

(1)

See reconciliations in the appendix of this supplemental.

(2)

Controllable expenses include utilities, food, repairs and maintenance, and other operating expenses.

(3)

Non-Controllable expenses include property taxes and insurance.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 4


 

ISHC Revenue per Payor and Bed Type

img33188571_4.jpg

Consolidated

 

Average Daily Rate

 

% of Resident Days

 

% of Revenue

 

Q3 2025

 

Q3 2026

 

% change

 

Q3 2025

 

Q3 2026

 

Q3 2025

 

Q3 2026

Medicare

$696.98

 

$726.38

 

4.2%

 

10.8%

 

10.0%

 

22.2%

 

20.6%

Medicare Advantage

$581.03

 

$611.05

 

5.2%

 

7.2%

 

7.8%

 

12.2%

 

13.6%

Private

$403.90

 

$430.66

 

6.6%

 

10.9%

 

10.9%

 

12.8%

 

13.3%

Managed care/insurance

$409.83

 

$511.16

 

24.7%

 

0.3%

 

0.4%

 

0.4%

 

0.6%

Medicaid

$320.73

 

$326.57

 

1.8%

 

24.4%

 

23.4%

 

22.8%

 

20.9%

Total skilled nursing

$449.21

 

$468.38

 

4.3%

 

53.6%

 

52.5%

 

70.4%

 

69.0%

Total senior housing

$190.01

 

$199.65

 

5.1%

 

46.4%

 

47.5%

 

25.7%

 

26.9%

Ancillary revenue

$13.35

 

$14.46

 

8.4%

 

0.0%

 

0.0%

 

3.9%

 

4.1%

Total

$339.64

 

$352.69

 

3.8%

 

100.0%

 

100.0%

 

100.0%

 

100.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quality Mix

 

 

 

 

 

 

75.6%

 

76.6%

 

77.2%

 

79.1%

 

Same-Store (1)

 

Average Daily Rate

 

% of Resident Days

 

% of Revenue

 

Q3 2025

 

Q3 2026

 

% change

 

Q3 2025

 

Q3 2026

 

Q3 2025

 

Q3 2026

Medicare

$697.45

 

$729.42

 

4.6%

 

11.3%

 

10.8%

 

23.4%

 

22.3%

Medicare Advantage

$579.12

 

$610.95

 

5.5%

 

7.4%

 

8.1%

 

12.8%

 

14.0%

Private

$404.70

 

$432.44

 

6.9%

 

11.1%

 

11.7%

 

13.4%

 

14.3%

Managed care/insurance

$408.19

 

$523.10

 

28.2%

 

0.3%

 

0.5%

 

0.4%

 

0.7%

Medicaid

$324.53

 

$335.74

 

3.5%

 

25.1%

 

24.3%

 

24.3%

 

23.0%

Total skilled nursing

$451.61

 

$474.92

 

5.2%

 

55.2%

 

55.4%

 

74.3%

 

74.3%

Total senior housing

$192.72

 

$203.16

 

5.4%

 

44.8%

 

44.6%

 

25.7%

 

25.7%

Total

$335.75

 

$353.78

 

5.4%

 

100.0%

 

100.0%

 

100.0%

 

100.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quality Mix

 

 

 

 

 

 

74.9%

 

75.7%

 

75.7%

 

77.0%

 

 

 

 

 

 

 

 

 

 

(1)
Does not include ancillary revenue.

American Healthcare REIT | Q3 2026 Supplemental | Page 5


 

Senior Housing Operating Properties

img33188571_5.jpg

(dollars in thousands, except RevPOR and ExPOR, and Pro-Rata)

Total Portfolio

 

 

Q3 2025

 

Q4 2025

 

Q1 2026

 

Q2 2026

 

Q3 2026

 

 

 

 

YTD 9/30/25

 

YTD 9/30/26

 

 

Properties

 

71

 

81

 

87

 

92

 

109

 

 

 

 

—

 

—

 

 

Consolidated total units

 

5,724

 

6,978

 

7,486

 

8,042

 

10,072

 

 

 

 

5,724

 

10,072

 

 

Consolidated average Occupancy

 

87.4%

 

89.0%

 

88.9%

 

88.8%

 

90.1%

 

 

 

 

86.1%

 

89.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash revenue (1)

 

$76,327

 

$91,134

 

$106,737

 

$121,361

 

$164,975

 

 

 

 

$216,034

 

$393,073

 

 

Operating expenses

 

61,001

 

71,423

 

80,957

 

89,894

 

119,200

 

 

 

 

174,943

 

290,051

 

 

Cash NOI (1)

 

$15,326

 

$19,711

 

$25,780

 

$31,467

 

$45,775

 

 

 

 

$41,091

 

$103,022

 

 

Cash NOI Margin %

 

20.1%

 

21.6%

 

24.2%

 

25.9%

 

27.7%

 

 

 

 

19.0%

 

26.2%

 

 

RevPOR

 

$5,177

 

$5,300

 

$5,600

 

$5,754

 

$6,613

 

 

 

 

$5,137

 

$6,038

 

 

ExPOR

 

$4,138

 

$4,154

 

$4,247

 

$4,262

 

$4,787

 

 

 

 

$4,161

 

$4,459

 

 

Consolidated Maintenance Capex

 

$4,559

 

$5,144

 

$3,586

 

$4,552

 

$7,698

 

 

 

 

$10,862

 

$15,836

 

 

 

Same-Store

 

 

Q3 2025

 

Q4 2025

 

Q1 2026

 

Q2 2026

 

Q3 2026

 

Q3 2026
vs
Q3 2025

 

 

YTD 9/30/25

 

YTD 9/30/26

 

YTD 2026 vs
YTD 2025

Properties

 

64

 

64

 

64

 

64

 

64

 

 

 

 

64

 

64

 

 

Consolidated units

 

5,103

 

5,103

 

5,107

 

5,107

 

5,127

 

 

 

 

5,103

 

5,127

 

 

Consolidated average Occupancy

 

87.6%

 

89.0%

 

88.6%

 

88.7%

 

90.0%

 

244 bps

 

 

86.5%

 

89.1%

 

259 bps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Same-Store revenue (1)

 

$68,675

 

$69,917

 

$71,199

 

$72,295

 

$74,853

 

9.0%

 

 

$202,413

 

$218,347

 

7.9%

Same-Store operating expenses

 

54,986

 

55,978

 

56,563

 

56,208

 

57,298

 

4.2%

 

 

163,142

 

170,069

 

4.2%

Compensation

 

33,413

 

33,959

 

34,333

 

34,369

 

34,845

 

4.3%

 

 

98,682

 

103,547

 

4.9%

Controllable (2)

 

18,492

 

18,759

 

19,097

 

18,750

 

19,169

 

3.7%

 

 

55,074

 

57,016

 

3.5%

Non-Controllable (3)

 

3,081

 

3,260

 

3,133

 

3,089

 

3,284

 

6.6%

 

 

9,386

 

9,506

 

1.3%

Same-Store NOI (1)

 

$13,689

 

$13,939

 

$14,636

 

$16,087

 

$17,555

 

28.2%

 

 

$39,271

 

$48,278

 

22.9%

Same-Store NOI Margin %

 

19.9%

 

19.9%

 

20.6%

 

22.3%

 

23.5%

 

352 bps

 

 

19.4%

 

22.1%

 

271 bps

RevPOR

 

$5,161

 

$5,164

 

$5,281

 

$5,354

 

$5,442

 

5.4%

 

 

$5,136

 

$5,360

 

4.4%

ExPOR

 

$4,132

 

$4,134

 

$4,195

 

$4,163

 

$4,166

 

0.8%

 

 

$4,139

 

$4,174

 

0.8%

 

 

 

 

(1)

See reconciliations in the appendix of this supplemental.

(2)

Controllable expenses include utilities, food, repairs and maintenance, and other operating expenses.

(3)

Non-Controllable expenses include property taxes and insurance.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 6


gfx33188571_0.jpg

img33188571_6.jpg

 

NOI Diversification

img33188571_5.jpg

(Presented by percentage of Q3 2026 Pro-Rata Cash NOI, excluding other non-recurring items)

By Partner

 

Campuses/
Properties

 

Beds/Units

 

ISHC

 

SHOP

 

SHOP+⁽¹⁾

Trilogy Management Services

149

 

15,105

 

100.0%

 

—

 

65.9%

Great Lakes Management

8

 

1,134

 

—

 

16.4%

 

5.6%

Heritage Senior Living

7

 

933

 

—

 

15.1%

 

5.1%

LCB Senior Living

8

 

872

 

—

 

14.9%

 

5.1%

Cogir Senior Living

14

 

904

 

—

 

10.5%

 

3.6%

Remaining

72

 

6,229

 

—

 

43.1%

 

14.7%

Total

258

 

25,177

 

100.0%

 

100.0%

 

100.0%

By State

 

Campuses/
Properties

 

Beds/Units

 

ISHC

 

SHOP

 

SHOP+⁽¹⁾

Indiana

75

 

7,520

 

52.8%

 

2.8%

 

35.8%

Ohio

39

 

4,197

 

20.4%

 

—

 

13.4%

Michigan

22

 

2,020

 

11.2%

 

1.7%

 

8.0%

Kentucky

19

 

1,808

 

11.5%

 

—

 

7.6%

Minnesota

7

 

992

 

—

 

14.2%

 

4.8%

California

10

 

1,249

 

—

 

12.3%

 

4.2%

Pennsylvania

7

 

750

 

—

 

10.9%

 

3.7%

Virginia

4

 

536

 

—

 

8.7%

 

3.0%

North Carolina

8

 

522

 

0.3%

 

6.0%

 

2.3%

Oregon

14

 

855

 

—

 

5.0%

 

1.7%

Remaining

53

 

4,728

 

3.8%

 

38.4%

 

15.5%

Total

258

 

25,177

 

100.0%

 

100.0%

 

100.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

SHOP+ consists of ISHC and SHOP. See Defined Terms section of the appendix for more details.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 7


OM by Location

img33188571_8.gif

 

Outpatient Medical

img33188571_7.jpg

(dollars and square feet in thousands, except revenue per square foot and Cash NOI per square foot)

Total Portfolio

 

 

Q3 2025

 

Q4 2025

 

Q1 2026

 

Q2 2026

 

Q3 2026

 

 

 

 

YTD 9/30/25

 

YTD 9/30/26

 

 

Properties

 

73

 

71

 

71

 

70

 

70

 

 

 

 

—

 

—

 

 

Consolidated GLA (Sq. Ft.)

 

3,825

 

3,685

 

3,685

 

3,654

 

3,654

 

 

 

 

3,825

 

3,654

 

 

Ending Occupancy

 

86.5%

 

88.9%

 

88.2%

 

88.4%

 

87.7%

 

 

 

 

86.5%

 

87.7%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash revenue (1)

 

$30,131

 

$29,558

 

$29,993

 

$29,495

 

$30,348

 

 

 

 

$93,013

 

$89,836

 

 

Operating expenses

 

11,458

 

11,236

 

11,826

 

11,214

 

11,825

 

 

 

 

35,483

 

34,865

 

 

Cash NOI (1)

 

$18,673

 

$18,322

 

$18,167

 

$18,281

 

$18,523

 

 

 

 

$57,530

 

$54,971

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash NOI Margin %

 

62.0%

 

62.0%

 

60.6%

 

62.0%

 

61.0%

 

 

 

 

61.9%

 

61.2%

 

 

Revenue per Sq. Ft.

 

$31.51

 

$32.08

 

$32.56

 

$32.29

 

$33.22

 

 

 

 

$32.42

 

$32.78

 

 

Cash NOI per Sq. Ft.

 

$19.53

 

$19.89

 

$19.72

 

$20.01

 

$20.28

 

 

 

 

$20.05

 

$20.06

 

 

Maintenance Capex

 

$4,924

 

$8,225

 

$2,107

 

$2,190

 

$3,568

 

 

 

 

$15,183

 

$7,865

 

 

Same-Store

 

 

Q3 2025

 

Q4 2025

 

Q1 2026

 

Q2 2026

 

Q3 2026

 

Q3 2026
vs
Q3 2025

 

 

YTD 9/30/25

 

YTD 9/30/26

 

YTD 2026 vs
YTD 2025

Properties

 

65

 

65

 

65

 

65

 

65

 

 

 

 

65

 

65

 

 

Consolidated GLA (Sq. Ft.)

 

3,259

 

3,259

 

3,259

 

3,260

 

3,260

 

 

 

 

3,259

 

3,260

 

 

Ending Occupancy

 

93.3%

 

93.4%

 

93.0%

 

92.6%

 

91.9%

 

(146 bps)

 

 

93.3%

 

91.9%

 

(146 bps)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Same-Store revenue (1)

 

$27,747

 

$27,627

 

$28,119

 

$27,722

 

$28,510

 

2.7%

 

 

$81,812

 

$84,351

 

3.1%

Same-Store operating expenses

 

10,250

 

9,885

 

10,870

 

10,331

 

10,943

 

6.8%

 

 

30,228

 

32,144

 

6.3%

Same-Store NOI (1)

 

$17,497

 

$17,742

 

$17,249

 

$17,391

 

$17,567

 

0.4%

 

 

$51,584

 

$52,207

 

1.2%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Same-Store NOI Margin %

 

63.1%

 

64.2%

 

61.3%

 

62.7%

 

61.6%

 

(144 bps)

 

 

63.1%

 

61.9%

 

(116 bps)

Same-Store revenue per Sq. Ft.

 

$34.06

 

$33.91

 

$34.51

 

$34.01

 

$34.98

 

 

 

 

$33.47

 

$34.50

 

 

Same-Store NOI per Sq. Ft.

 

$21.48

 

$21.78

 

$21.17

 

$21.34

 

$21.55

 

 

 

 

$21.10

 

$21.35

 

 

 

Tenants and Occupancy Metrics (as of September 30, 2026)

Tenants

ABR

 

%

 

S&P Credit Rating

Christus Good Shepherd Health System

$8,089

 

9.5%

 

A

Prime Healthcare

2,571

 

3.0%

 

B

Montefiore Medical Center

2,519

 

2.9%

 

BBB-

Atrius Health, Inc.

2,294

 

2.7%

 

A+

Cullman Regional Medical Center

1,994

 

2.3%

 

-

Remaining portfolio

68,094

 

79.6%

 

Various

Total

$85,560

 

100.0%

 

 

 

 

 

 

OM Absorption

 

Occupied Square Feet as of December 31, 2025

3,277

Expirations

(264)

Renewals

156

New leases

57

Terminations

(8)

Adjustment/remeasurement

(3)

Dispositions

(10)

Occupied Square Feet as of September 30, 2026

3,205

 

 

Trailing 12-months Retention

55.9%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

See reconciliations in the appendix of this supplemental.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 8


 

Triple-Net Leased Properties

img33188571_9.jpg

(dollars in thousands and Pro-Rata)

Total Portfolio

 

 

Q3 2025

 

Q4 2025

 

Q1 2026

 

Q2 2026

 

Q3 2026

 

 

 

 

YTD
9/30/25

 

YTD
9/30/26

 

 

Properties

 

18

 

18

 

18

 

17

 

17

 

 

 

 

—

 

—

 

 

AL/MC beds/units

 

538

 

538

 

538

 

538

 

538

 

 

 

 

538

 

538

 

 

SNF beds

 

882

 

882

 

882

 

826

 

826

 

 

 

 

882

 

826

 

 

Consolidated total beds/units (1)

 

1,420

 

1,420

 

1,420

 

1,364

 

1,364

 

 

 

 

1,420

 

1,364

 

 

Average operator Occupancy (1)

 

88.5%

 

89.2%

 

90.5%

 

90.5%

 

89.8%

 

 

 

 

88.9%

 

90.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash revenue (2)

 

$8,027

 

$8,053

 

$8,591

 

$8,119

 

$7,981

 

 

 

 

$24,499

 

$24,691

 

 

Debt investments

 

1,165

 

1,167

 

1,158

 

1,171

 

2,771

 

 

 

 

3,809

 

5,100

 

 

Operating expenses

 

495

 

456

 

958

 

661

 

405

 

 

 

 

2,213

 

2,024

 

 

Cash NOI (2)

 

$8,697

 

$8,764

 

$8,791

 

$8,629

 

$10,347

 

 

 

 

$26,095

 

$27,767

 

 

Cash NOI Margin %

 

94.6%

 

95.1%

 

90.2%

 

92.9%

 

96.2%

 

 

 

 

92.2%

 

93.2%

 

 

Same-Store

 

 

Q3 2025

 

Q4 2025

 

Q1 2026

 

Q2 2026

 

Q3 2026

 

Q3 2026
vs
Q3 2025

 

 

YTD
9/30/25

 

YTD
9/30/26

 

YTD 2026 vs
YTD 2025

Properties

 

17

 

17

 

17

 

17

 

17

 

 

 

 

17

 

17

 

 

Consolidated beds/units (1)

 

1,364

 

1,364

 

1,364

 

1,364

 

1,364

 

 

 

 

1,364

 

1,364

 

 

Average operator Occupancy (1)

 

88.2%

 

89.1%

 

90.6%

 

90.5%

 

89.8%

 

165 bps

 

 

88.7%

 

90.3%

 

162 bps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Same-Store revenue (2)

 

$7,870

 

$7,896

 

$8,078

 

$8,119

 

$7,981

 

1.4%

 

 

$23,455

 

$24,178

 

3.1%

Same-Store operating expenses

 

495

 

456

 

604

 

661

 

405

 

(18.2%)

 

 

1,630

 

1,670

 

2.5%

Same-Store NOI (2)

 

$7,375

 

$7,440

 

$7,474

 

$7,458

 

$7,576

 

2.7%

 

 

$21,825

 

$22,508

 

3.1%

Same-Store NOI Margin %

 

93.7%

 

94.2%

 

92.5%

 

91.9%

 

94.9%

 

122 bps

 

 

93.1%

 

93.1%

 

4 bps

Same-Store NOI (constant currency) (3)

 

$7,371

 

$7,455

 

$7,471

 

$7,461

 

$7,576

 

2.8%

 

 

$21,914

 

$22,508

 

2.7%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

Facilities are 100% triple-net leased and operators' occupancies exclude Hospitals.

(2)

See reconciliations in the appendix of this supplemental.

(3)

To eliminate the impact of exchange rate movements, the Company calculates Same-Store NOI on a constant currency basis, a non-GAAP measure, which includes currency adjustment for UK properties at September 30, 2026 YTD average GBP/USD rate of 1.34.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 9


 

Triple-Net Leased Properties Rent Coverage Stratification

img33188571_10.jpg

Tenant EBITDAR Coverage

 

Contribution to Pro-Rata Cash NOI at each Coverage Stratification for Q3 2026 (1)

Coverage

Senior Housing-Leased

SNFs

Hospitals

Total

WALT
(years)

Number of
Leases

< 0.80x

—

—

1.1%

1.1%

10.7

1

0.80x - 0.89x

—

—

—

—

—

—

0.90x - 0.99x

—

1.1%

—

1.1%

14.8

1

1.00x - 1.09x

0.4%

—

—

0.4%

5.7

1

1.10x - 1.19x

0.8%

—

—

0.8%

24.0

1

1.20x - 1.29x

—

—

—

—

—

—

1.30x - 1.39x

—

—

—

—

—

—

1.40x - 1.49x

—

—

—

—

—

—

1.50x - 1.59x

—

—

—

—

—

—

1.60x - 1.69x

—

—

—

—

—

—

1.70x - 1.79x

—

—

—

—

—

—

1.80x - 1.89x

—

—

—

—

—

—

1.90x - 1.99x

—

—

—

—

—

—

> 2.00x

—

0.8%

0.2%

1.0%

4.7

2

Total

1.2%

1.9%

1.3%

4.4%

12.1

6

 

 

 

 

 

 

 

Segment rent coverage (2)

1.14x

1.52x

0.98x

1.24x

 

 

 

 

 

 

 

 

 

Tenant Occupancy

89.0%

90.4%

N/A

89.8%

 

 

 

 

Tenant EBITDARM Coverage

 

Contribution to Pro-Rata Cash NOI at each Coverage Stratification for Q3 2026 (1)

Coverage

Senior Housing-Leased

SNFs

Hospitals

Total

WALT
(years)

Number of
Leases

< 0.80x

—

—

1.1%

1.1%

10.7

1

0.80x - 0.89x

—

—

—

—

—

—

0.90x - 0.99x

—

—

—

—

—

—

1.00x - 1.09x

—

—

—

—

—

—

1.10x - 1.19x

—

—

—

—

—

—

1.20x - 1.29x

0.4%

—

—

0.4%

5.7

1

1.30x - 1.39x

—

—

—

—

—

—

1.40x - 1.49x

0.8%

1.1%

—

1.9%

17.8

2

1.50x - 1.59x

—

—

—

—

—

—

1.60x - 1.69x

—

—

—

—

—

—

1.70x - 1.79x

—

—

—

—

—

—

1.80x - 1.89x

—

—

—

—

—

—

1.90x - 1.99x

—

—

—

—

—

—

> 2.00x

—

0.8%

0.2%

1.0%

4.7

2

Total

1.2%

1.9%

1.3%

4.4%

12.1

6

 

 

 

 

 

 

 

Segment rent coverage (2)

1.39x

2.02x

1.23x

1.59x

 

 

 

 

 

 

 

 

 

Tenant Occupancy

89.0%

90.4%

N/A

89.8%

 

 

 

 

 

(1)

Represents trailing twelve month coverage metrics as of June 30, 2026. Percentages are based on Pro-Rata Cash NOI for the three month ended
September 30, 2026.

(2)

Represents combined coverage metrics for all leases within each property type and total segment.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 10


 

Revenue and Lease Expiration (1)

img33188571_11.jpg

(dollars in thousands, as of September 30, 2026)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OM

 

Triple-Net Leased Properties

 

 

 

 

 

 

Year

 

ABR (2)

%
of ABR

 

# of Expiring Leases

Total
Sq. Ft.

 

%
of GLA

 

ABR (2)

%
of ABR

 

Interest Income (3)

 

Total

2026

 

$645

0.7%

 

14

54

 

1.7%

 

$—

0.0%

 

$—

0.0%

 

$645

0.4%

2027

 

8,332

8.5%

 

59

292

 

9.0%

 

—

0.0%

 

6,922

63.3%

 

15,254

10.5%

2028

 

14,221

14.5%

 

65

487

 

15.1%

 

—

0.0%

 

4,013

36.7%

 

18,234

12.5%

2029

 

14,825

15.1%

 

68

524

 

16.2%

 

—

0.0%

 

—

0.0%

 

14,825

10.2%

2030

 

11,541

11.8%

 

50

379

 

11.7%

 

5,779

15.8%

 

—

0.0%

 

17,320

11.9%

Thereafter

 

48,651

49.4%

 

139

1,495

 

46.3%

 

30,773

84.2%

 

—

0.0%

 

79,424

54.5%

Total

 

$98,215

100.0%

 

395

3,231

 

100.0%

 

$36,552

100.0%

 

$10,935

100.0%

 

$145,702

100.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)
Excludes ISHC and SHOP.
(2)
Total ABR expiring in the applicable year. Month-to-month leases are included as expirations in 2026.
(3)
Represents total interest income from debt investments.

American Healthcare REIT | Q3 2026 Supplemental | Page 11


 

Debt Maturities

img33188571_11.jpg

(dollars in thousands, as of September 30, 2026)

Period

 

Lines of Credit
and Term
Loan

 

Mortgage
Loans
Payable

 

Combined
Debt

 

% of
Combined
Debt

 

Weighted
Average
Interest
Rate
(2)_(3)

2026

 

$—

 

$4,888

 

$4,888

 

0.4%

 

3.52%

2027

 

550,000

 

56,182

 

606,182

 

43.9%

 

4.74%

2028

 

—

 

139,740

 

139,740

 

10.1%

 

4.40%

2029

 

—

 

16,963

 

16,963

 

1.2%

 

3.36%

2030

 

—

 

44,732

 

44,732

 

3.2%

 

4.51%

Thereafter (1)

 

—

 

568,262

 

568,262

 

41.2%

 

3.74%

Total

 

$550,000

 

$830,767

 

$1,380,767

 

100.0%

 

 

Weighted interest rate (2)_(3)

 

4.86%

 

3.87%

 

4.26%

 

 

 

 

Weighted average maturity (years)

 

0.3

 

20.7

 

12.6

 

 

 

 

Percentage of variable-rate debt

 

— %

 

— %

 

— %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

Debt maturing after 2030 has a weighted average maturity date of April 2053 (27 Years).

(2)

Interest rates reflect two in-place swap derivatives for $350 million and $200 million with strikes at 3.51% and 3.52%, respectively, which mature on January 19, 2027.

(3)

Does not include interest rate impact from mortgage insurance premiums and equipment financing.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 12


 

2026 Real Estate Acquisitions and Dispositions

img33188571_11.jpg

(dollars in thousands)

Acquisitions

Reportable Segment/Quarter

 

Number of Properties

 

Beds/Units

 

Gross Purchase Price

 

Average
Cost per
Bed/Unit

SHOP

 

 

 

 

 

 

 

 

Q1 2026

 

7

 

501

 

$162,750

 

$325

Q2 2026

 

5

 

558

 

126,917

 

227

Q3 2026

 

17

 

2,011

 

1,693,000

 

842

Total

 

29

 

3,070

 

$1,982,667

 

$646

 

 

Dispositions

Reportable Segment/Quarter

 

Number of Properties/ Campuses

 

Beds/Units/GLA (1)

 

Gross Proceeds

 

 

ISHC

 

 

 

 

 

 

 

 

Q2 2026

 

1

 

83

 

$14,150

 

 

 

 

 

 

 

 

 

 

 

OM

 

 

 

 

 

 

 

 

Q2 2026

 

1

 

32

 

1,000

 

 

 

 

 

 

 

 

 

 

 

Triple-Net Leased Properties

 

 

 

 

 

 

 

 

Q2 2026

 

1

 

56

 

7,100

 

 

 

 

 

 

 

 

 

 

 

Total

 

3

 

 

 

$22,250

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

OM presents GLA in thousands, rather than Beds/Units.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 13


 

Real Estate Developments & Expansions

img33188571_11.jpg

(dollars in thousands)

 

In-Process Pipeline

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Development Timing

Project Name

 

State

 

Segment

 

Type of
Project

 

Beds/Units

 

Spent to
Date

 

Total
Expected
Cost

 

Construction
Start

 

Expected
Completion

Portage

 

MI

 

ISHC

 

New Campus

 

108

 

$25,344

 

$25,344

 

Q3 2024

 

Q4 2026

Mooresville

 

IN

 

ISHC

 

Wing Expansion

 

27

 

4,329

 

4,463

 

Q1 2025

 

Q4 2026

Scio Township

 

MI

 

ISHC

 

New Campus

 

109

 

14,339

 

26,651

 

Q3 2025

 

Q2 2027

Holly

 

MI

 

ISHC

 

New Campus

 

114

 

5,320

 

29,692

 

Q3 2025

 

Q1 2028

Lowell

 

IN

 

ISHC

 

IL Villas

 

50

 

4,033

 

14,484

 

Q3 2025

 

Q3 2027

Noblesville

 

IN

 

ISHC

 

IL Villas

 

32

 

5,914

 

10,401

 

Q3 2025

 

Q4 2026

Lafayette

 

IN

 

ISHC

 

IL Villas

 

8

 

1,561

 

2,505

 

Q3 2025

 

Q4 2026

LaGrange

 

KY

 

ISHC

 

IL Villas

 

26

 

6,047

 

8,791

 

Q3 2025

 

Q1 2027

Tiffin

 

OH

 

ISHC

 

IL Villas

 

30

 

2,751

 

8,429

 

Q3 2025

 

Q2 2027

Tiffin

 

OH

 

ISHC

 

Wing Expansion

 

18

 

1,245

 

2,968

 

Q3 2025

 

Q1 2027

Jasper

 

IN

 

ISHC

 

Wing Expansion

 

17

 

777

 

2,754

 

Q3 2025

 

Q2 2027

Warsaw

 

IN

 

ISHC

 

Wing Expansion

 

24

 

5,908

 

5,908

 

Q3 2025

 

Q4 2026

Waunakee - Phase I

 

WI

 

ISHC

 

New Campus

 

108

 

2,796

 

3,760

 

Q1 2026

 

Q4 2026

Delaware City

 

OH

 

ISHC

 

New Campus

 

136

 

5,606

 

35,032

 

Q2 2026

 

Q1 2028

Sun Prairie

 

WI

 

ISHC

 

Wing Expansion

 

10

 

1,205

 

2,069

 

Q2 2026

 

Q4 2026

Kendallville

 

IN

 

ISHC

 

IL Villas

 

32

 

1,028

 

9,613

 

Q3 2026

 

Q4 2027

Total

 

 

 

 

 

 

 

849

 

$88,203

 

$192,864

 

 

 

 

 

 

 

 

Completed Projects (1)

Project Name

 

State

 

Segment

 

Type of
Project

 

Beds/Units

 

Total Cost

 

Construction
Completion

 

 

 

 

Harrodsburg

 

KY

 

ISHC

 

IL Villas

 

32

 

$9,622

 

Q1 2026

 

 

 

 

Sylvania

 

OH

 

ISHC

 

IL Villas

 

26

 

8,741

 

Q1 2026

 

 

 

 

Ottawa

 

OH

 

ISHC

 

IL Villas

 

30

 

8,511

 

Q1 2026

 

 

 

 

Greenfield

 

IN

 

ISHC

 

IL Villas

 

16

 

4,731

 

Q2 2026

 

 

 

 

Howell

 

MI

 

ISHC

 

Wing Expansion

 

36

 

2,346

 

Q3 2026

 

 

 

 

Total

 

 

 

 

 

 

 

140

 

$33,951

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

Includes projects that have been completed through YTD September 30, 2026. Certain projects that have been completed may not yet be stabilized.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 14


 

Full Year 2026 Guidance (1)

img33188571_11.jpg

(dollars in millions, except per share)

NAREIT FFO and Normalized FFO Attributable to Common Stockholders Reconciliation

 

Current

 

 

Prior

 

 

Guidance Adjustment ⁽²⁾

 

 

Low

 

High

 

 

Low

 

High

 

 

Net income attributable to common stockholders

$

123.2

 

$

129.2

 

 

$

108.5

 

$

116.5

 

 

$

13.7

 

Depreciation and amortization ⁽³⁾

 

322.1

 

 

322.1

 

 

 

306.8

 

 

306.8

 

 

 

15.3

 

Impairment and gain/losses from dispositions ⁽³⁾

 

(3.5

)

 

(3.5

)

 

 

(3.9

)

 

(3.9

)

 

 

0.4

 

NAREIT FFO attributable to common stockholders

$

441.8

 

$

447.8

 

 

$

411.4

 

$

419.4

 

 

$

29.4

 

Amortization of other intangible assets/liabilities ⁽³⁾

 

2.7

 

 

2.7

 

 

 

1.3

 

 

1.3

 

 

 

1.4

 

Change in deferred rent ⁽³⁾

 

(1.3

)

 

(1.3

)

 

 

(1.6

)

 

(1.6

)

 

 

0.3

 

Non-cash impact of changes to equity plan ⁽³⁾⁽⁴⁾

 

26.3

 

 

26.3

 

 

 

21.9

 

 

21.9

 

 

 

4.4

 

Other adjustments ⁽⁵⁾

 

(6.2

)

 

(6.2

)

 

 

(0.2

)

 

(0.2

)

 

 

(6.0

)

Normalized FFO attributable to common stockholders

$

463.3

 

$

469.3

 

 

$

432.8

 

$

440.8

 

 

$

29.5

 

Weighted average diluted shares (in millions)

 

207.7

 

 

207.7

 

 

 

201.3

 

 

201.3

 

 

 

6.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to common stockholders - per share

$

0.59

 

$

0.62

 

 

$

0.54

 

$

0.58

 

 

$

0.045

 

NAREIT FFO attributable to common stockholders - per share

$

2.13

 

$

2.16

 

 

$

2.04

 

$

2.08

 

 

$

0.085

 

NFFO attributable to common stockholders - per share

$

2.23

 

$

2.26

 

 

$

2.15

 

$

2.19

 

 

$

0.075

 

Same-Store NOI Growth

 

Current

 

Prior

 

Guidance Adjustment ⁽²⁾

 

Low

High

 

Low

High

 

Total Portfolio Same-Store NOI Growth

12.0%

14.0%

 

11.0%

13.0%

 

100 bps

Segment-Level Same-Store NOI Growth:

 

 

 

 

 

 

 

   ISHC

14.5%

16.5%

 

13.0%

16.0%

 

100 bps

   SHOP

23.0%

26.0%

 

18.0%

21.0%

 

500 bps

   Outpatient Medical

0.5%

1.0%

 

—

1.0%

 

25 bps

   Triple-Net Leased Properties

2.5%

3.5%

 

2.0%

3.0%

 

50 bps

Other Select Guidance Assumptions

 

Current

 

 

Prior

 

 

Guidance Adjustment ⁽²⁾

 

 

Low

 

High

 

 

Low

 

High

 

 

General and administrative expenses

$

74

 

$

78

 

 

$

74

 

$

78

 

 

 

—

 

Interest expense

$

74

 

$

77

 

 

$

75

 

$

79

 

 

$

(1.5

)

Other income, net

$

6

 

$

9

 

 

$

5

 

$

8

 

 

$

1.0

 

Development funding – new starts and on-going projects

$

100

 

$

110

 

 

$

150

 

$

170

 

 

$

(55.0

)

Acquisitions / Investments

No additional acquisitions or investments beyond ~$2.1B closed YTD

 

 

No additional acquisitions or investments beyond ~$1.4B closed YTD

 

 

 

 

 

(1)
The Company's guidance constitutes forward-looking statements within the meaning of the federal securities laws and is based on a number of assumptions that are subject to change and many of which are outside of the Company's control. Actual results may differ materially from the Company's expectations depending on factors discussed herein and in the Company's filings with the Securities and Exchange Commission. Totals may not add due to rounding. Non-GAAP financial measures and other terms, as used in this supplemental, are also defined and further explained in the appendix. The Company is unable to provide, without unreasonable effort, guidance for the most comparable GAAP financial measures of total revenues and property operating and maintenance expenses. Additionally, a reconciliation of the forward-looking non-GAAP financial measures of Same-Store NOI growth to the comparable GAAP financial measures cannot be provided without unreasonable effort because the Company is unable to reasonably predict certain items contained in the GAAP measures, including non-recurring and infrequent items that are not indicative of the Company's ongoing operations. Such items include, but are not limited to, impairment on depreciated real estate assets, net gain or loss on sale of real estate assets, stock-based compensation, casualty loss, non-Same-Store revenue, and non-Same-Store operating expenses. These items are uncertain, depend on various factors, and could have a material impact on the Company's GAAP results for the guidance period. See reconciliations in the appendix of this presentation.
(2)
Reflects changes between current and prior guidance range at the midpoint.
(3)
Amounts are presented net of noncontrolling interests' share and AHR's share of unconsolidated entities.
(4)
Amounts represent amortization of equity compensation and fair value adjustments to performance-based equity compensation.
(5)
Includes adjustments for capitalized interest, transaction, transition and restructuring costs and additional items as noted in the Company’s definition for NFFO.

American Healthcare REIT | Q3 2026 Supplemental | Page 15


 

Components of NAV (1)

img33188571_12.jpg

(dollars and square feet in thousands)

Segment

 

Campuses/
Properties

Square
Feet

Total
Beds/Units

Q3 2026
Cash NOI
 (2)

Q3 2026 Annualized
Cash NOI
 (2)

ISHC

 

148

11,377

14,998

$87,530

$350,120

SHOP (3)

 

109

9,380

10,072

46,016

184,064

Outpatient Medical

 

69

3,643

 

18,570

74,280

Triple-Net Leased Properties (3)

 

17

961

1,364

7,774

31,096

Total

 

343

25,361

26,434

$159,890

$639,560

 

Obligations

 

Pro-Rata

 

Consolidated

 

Weighted Avg.
Interest Rate

Mortgage debt

 

$830,767

 

$830,767

 

3.87%

Revolving LOC

 

—

 

—

 

4.97%

Term loan(4)

 

550,000

 

550,000

 

4.86%

Total debt

 

1,380,767

 

1,380,767

 

 

Cash, cash equivalents and restricted cash pertaining to debt

 

(247,566)

 

(247,702)

 

 

Net Debt

 

$1,133,201

 

$1,133,065

 

 

Other tangible liabilities, net:

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$371,534

 

$371,593

 

 

Other

 

66,457

 

66,538

 

 

Total other tangible liabilities, net

 

437,991

 

438,131

 

 

Financing

 

19,146

 

19,147

 

 

Lease obligations

 

135,422

 

135,430

 

 

Net obligations

 

$1,725,760

 

$1,725,773

 

 

 

 

 

 

 

 

 

Other Assets

 

 

 

 

 

 

Debt investments, gross

 

$238,254

 

$238,254

 

 

Other tangible assets:

 

 

 

 

 

 

Accounts receivable

 

228,503

 

228,503

 

 

Capital expenditures

 

132,633

 

132,645

 

 

Inventory

 

21,352

 

21,352

 

 

Other

 

60,635

 

60,656

 

 

Total other tangible assets

 

443,123

 

443,156

 

 

Sold assets/assets expected to be sold

 

18,000

 

18,000

 

 

Total other assets

 

$699,377

 

$699,410

 

 

 

 

 

 

 

 

 

Common Shares and OP Units Issued and Outstanding

 

 

 

 

 

 

Total common shares

 

231,479,253

 

231,479,253

 

 

Total OP Units

 

1,936,425

 

1,936,425

 

 

Total common shares and OP Units

 

233,415,678

 

233,415,678

 

 

 

 

 

(1)
Dollars, square feet and beds/units are presented on a consolidated basis as of September 30, 2026.
(2)
Cash NOI is adjusted to exclude non-recurring items for the three months ended September 30, 2026.
(3)
Excludes interest income from debt investments.
(4)
Weighted average rates reflect in-place swap derivatives.

American Healthcare REIT | Q3 2026 Supplemental | Page 16


img33188571_13.jpg

Holbrook Sugar Hill

Sugar Hill, GA

Third Quarter 2026

Supplemental Appendix

 

Non-GAAP Reconciliations

&

Defined Terms

 

 

 

 

American Healthcare REIT | Q3 2026 Supplemental | Page 17


 

NAREIT FFO/NFFO Reconciliation (1)

img33188571_12.jpg

(in thousands, except shares and per share amounts)

 

Q3 2026

 

Q3 2025

 

YTD
9/30/26

 

YTD
9/30/25

Net income

 

$31,515

 

$56,639

 

$86,506

 

$59,878

Depreciation and amortization related to real estate — consolidated properties

 

90,800

 

49,115

 

229,849

 

131,980

Depreciation and amortization related to real estate — unconsolidated entities

 

43

 

15

 

71

 

1,018

Impairment of real estate investments — consolidated properties

 

—

 

3,768

 

2,137

 

38,133

(Gain) loss on dispositions of real estate investments, net — consolidated properties

 

—

 

(691)

 

(5,647)

 

2,344

Gain on re-measurement of previously held equity interest

 

—

 

(14,580)

 

—

 

(14,580)

Net income attributable to noncontrolling interests

 

(302)

 

(712)

 

(974)

 

(847)

Depreciation, amortization, impairments, net gain/loss on dispositions and gain on re-measurement —
   noncontrolling interests

 

(1,449)

 

(521)

 

(3,005)

 

(2,216)

NAREIT FFO attributable to controlling interest

 

120,607

 

93,033

 

308,937

 

215,710

Transaction, transition and restructuring costs

 

5,113

 

50

 

9,870

 

1,808

Amortization of above- and below-market leases

 

281

 

295

 

911

 

1,063

Amortization of direct origination and closing costs — debt investments

 

739

 

11

 

763

 

60

Change in deferred rent

 

(184)

 

(485)

 

(1,120)

 

(1,877)

Non-cash impact of changes to equity instruments (2)

 

9,284

 

3,429

 

19,909

 

9,170

Non-cash income tax benefit

 

(294)

 

(21,401)

 

(1,241)

 

(21,401)

Capitalized interest

 

(834)

 

(401)

 

(2,189)

 

(843)

(Gain) loss on debt extinguishments

 

—

 

(22)

 

147

 

1,784

Loss (gain) in fair value of derivative financial instruments

 

106

 

(166)

 

(1,778)

 

1,213

Foreign currency loss (gain)

 

619

 

977

 

1,363

 

(3,181)

Other non-recurring income (3)

 

(8,815)

 

—

 

(8,815)

 

—

Adjustments for unconsolidated entities

 

(1)

 

(1)

 

(2)

 

4

Adjustments for noncontrolling interests

 

(62)

 

211

 

(192)

 

139

Normalized FFO attributable to controlling interest

 

$126,559

 

$75,530

 

$326,563

 

$203,649

NAREIT FFO per common share attributable to controlling interest — diluted

 

$0.55

 

$0.54

 

$1.55

 

$1.32

Normalized FFO per common share attributable to controlling interest — diluted

 

$0.58

 

$0.44

 

$1.64

 

$1.25

NAREIT FFO and Normalized FFO weighted average common share outstanding — diluted

 

217,711,583

 

169,802,090

 

199,494,794

 

162,908,219

Distributions paid to common stockholders

 

$48,783

 

$41,241

 

$143,214

 

$120,666

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)
Totals may not add due to rounding.
(2)
For the three and nine months ended September 30, 2026, stock compensation expense includes $4,594,000 related to the accelerated vesting and modification of certain outstanding equity awards in connection with our previously disclosed Chief Executive Officer and Chief Financial Officer transitions during the third quarter of 2026, net of forfeitures.
(3)
Represents certain Ohio Medicaid quality incentive payments received by our ISHC segment pursuant to Ohio House Bill 479, or HB 479, that do not relate to the 2026 rate period. HB 479 was enacted in June 2026 and appropriated funding for nursing facility quality incentive payments. These amounts are included in resident fees and services revenue in our condensed consolidated statements of operations and comprehensive income, but are not reflective of our on-going operating performance.

American Healthcare REIT | Q3 2026 Supplemental | Page 18


 

Adjusted EBITDA, Coverage Ratios & Net Debt Reconciliation

img33188571_12.jpg

(dollars in thousands)

Adjusted EBITDA Reconciliation

 

Q3 2026

 

 

 

 

Net income

$31,515

 

 

 

 

Interest expense, net (including amortization of deferred financing costs and amortization of debt
  discount/premium)

17,773

 

Income tax expense

740

 

Depreciation and amortization (including amortization of leased assets and accretion of lease liabilities)

91,403

 

 

 

 

EBITDA

141,431

 

 

 

 

Income from unconsolidated entities

(49)

 

Straight line rent and amortization of above/below market leases

(437)

 

Non-cash impact of changes to equity instruments

9,284

 

Transaction, transition and restructuring costs

5,113

 

Amortization of direct origination and closing costs — debt investments

739

 

Foreign currency loss

619

 

Loss in fair value of derivative financial instruments

106

 

Other non-recurring income

(8,815)

 

 

 

 

Adjusted EBITDA

$147,991

 

 

Coverage Ratios and Net Debt Reconciliation

 

Q3 2026

 

Interest Coverage Ratios

 

 

Interest expense(1)

$17,773

 

Capitalized interest

834

 

Non-cash interest expense(2)

(1,553)

 

Total Interest

$17,054

 

 

 

 

Interest Coverage Ratio(3)

8.7X

 

 

 

 

Fixed Charge Coverage Ratio

 

 

Total interest

$17,054

 

Secured debt principal amortization

4,826

 

Total Fixed Charge

$21,880

 

 

 

 

Fixed Charge Coverage Ratio(3)

6.8X

 

 

 

 

Total debt

$1,380,767

 

Cash and cash equivalents

(222,767)

 

Restricted cash related to debt

(24,935)

 

Net Debt

$1,133,065

 

 

 

 

Net Debt-to-Annualized Adjusted EBITDA

1.9X

 

 

 

(1)

Includes approximately $1.4 million of cash interest expense from financing obligations, mortgage insurance premiums, and equipment financing.

(2)

Non-cash interest expense includes amortization of loan fees and debt discount/premium.

(3)

Interest Coverage Ratio calculated as Adjusted EBITDA divided by Total Interest. Fixed Charge Coverage Ratio calculated as Adjusted EBITDA divided by Total Fixed Charge.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 19


 

Same-Store Property Reconciliation

img33188571_11.jpg

 

 

Total Property Count Reconciliation

 

ISHC

 

SHOP

 

OM

 

Triple-Net Leased Properties

 

Total

Prior quarter total property count (2Q26)

 

148

 

92

 

70

 

17

 

327

  3Q26 acquisitions

 

—

 

17

 

—

 

—

 

17

  3Q26 completed expansion

 

1

 

—

 

—

 

—

 

1

Current quarter total property count (3Q26)

 

149

 

109

 

70

 

17

 

345

   Recent acquisitions

 

(23)

 

(43)

 

—

 

—

 

(66)

   Non-Core Properties

 

(1)

 

(1)

 

(5)

 

—

 

(7)

   Expansion and developments

 

(10)

 

(1)

 

—

 

—

 

(11)

Quarterly Same-Store property count (3Q26)

 

115

 

64

 

65

 

17

 

261

 

 

 

 

 

 

 

 

 

 

 

Sequential Same-Store reconciliation

 

ISHC

 

SHOP

 

OM

 

Triple-Net Leased Properties

 

Total

Quarterly Same-Store property count (2Q26)

 

115

 

64

 

65

 

17

 

261

   Recent acquisitions

 

—

 

—

 

—

 

—

 

—

   Dispositions

 

—

 

—

 

—

 

—

 

—

   Expansion and developments

 

—

 

—

 

—

 

—

 

—

Current quarterly Same-Store property count (3Q26)

 

115

 

64

 

65

 

17

 

261

 

American Healthcare REIT | Q3 2026 Supplemental | Page 20


 

Cash NOI Reconciliation

img33188571_12.jpg

(in thousands)

 

Q3 2026

 

Q2 2026

 

Q1 2026

 

Q4 2025

 

Q3 2025

 

YTD 9/30/26

 

YTD 9/30/25

Net income

$31,515

 

$30,980

 

$24,011

 

$10,940

 

$56,639

 

$86,506

 

$59,878

General and administrative

21,582

 

19,891

 

17,605

 

16,529

 

14,108

 

59,078

 

42,206

Transaction, transition and restructuring costs

5,113

 

2,786

 

1,971

 

3,295

 

50

 

9,870

 

1,808

Depreciation and amortization

90,869

 

72,125

 

67,062

 

55,323

 

49,181

 

230,056

 

132,236

Interest expense

17,773

 

18,626

 

18,796

 

19,806

 

20,392

 

55,195

 

65,969

Loss (gain) in fair value of derivative financial instruments

106

 

(357)

 

(1,527)

 

(179)

 

(166)

 

(1,778)

 

1,213

(Gain) loss on dispositions of real estate investments, net

—

 

(5,647)

 

—

 

621

 

(691)

 

(5,647)

 

2,344

Impairment of real estate investments

—

 

1,719

 

418

 

11,802

 

3,768

 

2,137

 

38,133

(Income) loss from unconsolidated entities

(49)

 

(892)

 

(792)

 

(657)

 

(462)

 

(1,733)

 

2,624

Gain on re-measurement of previously held equity interest

—

 

—

 

—

 

—

 

(14,580)

 

—

 

(14,580)

Foreign currency loss (gain)

619

 

(75)

 

819

 

6

 

977

 

1,363

 

(3,181)

Other income, net

(3,473)

 

(1,914)

 

(2,335)

 

(3,491)

 

(2,309)

 

(7,722)

 

(5,314)

Income tax expense (benefit)

740

 

(3)

 

(525)

 

(2,415)

 

(21,092)

 

212

 

(19,756)

Total NOI

164,795

 

137,239

 

125,503

 

111,580

 

105,815

 

427,537

 

303,580

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Straight line rent

(297)

 

(503)

 

(780)

 

(793)

 

(730)

 

(1,580)

 

(2,286)

Facility rental expense

6,752

 

6,752

 

6,761

 

6,849

 

7,030

 

20,265

 

21,807

Other non-cash adjustments

934

 

77

 

14

 

163

 

133

 

1,025

 

517

Cash NOI from dispositions

(6)

 

(355)

 

10

 

27

 

(102)

 

(351)

 

(716)

Cash NOI attributable to noncontrolling interests (1)

(734)

 

(250)

 

(250)

 

(250)

 

(251)

 

(1,234)

 

(758)

Cash NOI (1)

$171,444

 

$142,960

 

$131,258

 

$117,576

 

$111,895

 

$445,662

 

$322,144

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

All periods are based upon current quarter's ownership percentage.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 21


 

Same-Store Revenue Reconciliation

img33188571_14.jpg

(in thousands)

 

 

Q3 2026

 

Q2 2026

 

Q1 2026

 

Q4 2025

 

Q3 2025

 

YTD 9/30/26

 

YTD 9/30/25

Integrated Senior Health Campuses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Revenue

 

$534,189

 

$512,878

 

$502,743

 

$472,577

 

$455,452

 

$1,549,810

 

$1,313,494

Cash revenue from dispositions

 

—

 

(2,069)

 

—

 

—

 

1

 

(2,069)

 

(2,680)

Cash revenue

 

534,189

 

510,809

 

502,743

 

472,577

 

455,453

 

1,547,741

 

1,310,814

Revenue attributable to new acquisitions/dispositions/other

 

(177,351)

 

(169,742)

 

(160,081)

 

(132,515)

 

(118,985)

 

(507,174)

 

(330,145)

Revenue attributable to Non-Core Properties

 

(3,576)

 

(3,568)

 

(6,554)

 

(6,680)

 

(6,655)

 

(13,698)

 

(19,258)

Other normalizing revenue adjustments

 

(7,772)

 

—

 

—

 

—

 

—

 

(7,772)

 

—

Same-Store revenue

 

$345,490

 

$337,499

 

$336,108

 

$333,382

 

$329,813

 

$1,019,097

 

$961,411

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SHOP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Revenue

 

$166,904

 

$121,641

 

$107,024

 

$91,410

 

$76,606

 

$395,569

 

$217,025

Cash revenue from dispositions

 

—

 

—

 

—

 

—

 

(1)

 

—

 

(167)

Cash revenue attributable to noncontrolling interests (1)

 

(1,929)

 

(280)

 

(287)

 

(276)

 

(278)

 

(2,496)

 

(824)

Cash revenue (1)

 

164,975

 

121,361

 

106,737

 

91,134

 

76,327

 

393,073

 

216,034

Revenue attributable to new acquisitions/dispositions

 

(88,418)

 

(47,447)

 

(34,027)

 

(19,788)

 

(6,208)

 

(169,892)

 

(9,617)

Revenue attributable to development conversion

 

(1,105)

 

(1,014)

 

(904)

 

(897)

 

(864)

 

(3,023)

 

(2,255)

Revenue attributable to Non-Core Properties

 

(599)

 

(605)

 

(607)

 

(532)

 

(580)

 

(1,811)

 

(1,749)

Same-Store revenue (1)

 

$74,853

 

$72,295

 

$71,199

 

$69,917

 

$68,675

 

$218,347

 

$202,413

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outpatient Medical

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Revenue

 

$30,666

 

$29,985

 

$30,842

 

$30,449

 

$31,181

 

$91,493

 

$95,629

Straight line rent

 

24

 

(100)

 

(358)

 

(363)

 

(243)

 

(434)

 

(675)

Other non-cash adjustments

 

(343)

 

(389)

 

(491)

 

(356)

 

(380)

 

(1,223)

 

(1,054)

Cash revenue from dispositions

 

1

 

(1)

 

—

 

(172)

 

(427)

 

—

 

(887)

Cash revenue

 

30,348

 

29,495

 

29,993

 

29,558

 

30,131

 

89,836

 

93,013

Revenue attributable to dispositions

 

—

 

—

 

—

 

—

 

(154)

 

—

 

(4,044)

Revenue attributable to Non-Core Properties

 

(1,838)

 

(1,773)

 

(1,874)

 

(1,931)

 

(2,230)

 

(5,485)

 

(7,157)

Same-Store revenue

 

$28,510

 

$27,722

 

$28,119

 

$27,627

 

$27,747

 

$84,351

 

$81,812

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Triple-Net Leased Properties

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Revenue

 

$10,390

 

$9,746

 

$10,165

 

$9,644

 

$9,698

 

$30,301

 

$29,895

Straight line rent

 

(321)

 

(403)

 

(422)

 

(430)

 

(487)

 

(1,146)

 

(1,611)

Other non-cash adjustments

 

881

 

169

 

200

 

200

 

200

 

1,250

 

624

Cash revenue from dispositions

 

—

 

(27)

 

—

 

—

 

(25)

 

(27)

 

(25)

Cash revenue attributable to noncontrolling interest (1)

 

(198)

 

(195)

 

(194)

 

(194)

 

(194)

 

(587)

 

(575)

Cash revenue (1)

 

10,752

 

9,290

 

9,749

 

9,220

 

9,192

 

29,791

 

28,308

Debt investments (2)

 

(2,771)

 

(1,171)

 

(1,158)

 

(1,167)

 

(1,165)

 

(5,100)

 

(3,809)

Revenue attributable to dispositions

 

—

 

—

 

—

 

—

 

—

 

—

 

(52)

Revenue attributable to Non-Core Properties

 

—

 

—

 

(159)

 

(157)

 

(157)

 

(159)

 

(470)

Other normalizing revenue adjustments

 

—

 

—

 

(354)

 

—

 

—

 

(354)

 

(522)

Same-Store revenue (1)

 

$7,981

 

$8,119

 

$8,078

 

$7,896

 

$7,870

 

$24,178

 

$23,455

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Portfolio

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Revenue

 

$742,149

 

$674,250

 

$650,774

 

$604,080

 

$572,937

 

$2,067,173

 

$1,656,043

Straight line rent

 

(297)

 

(503)

 

(780)

 

(793)

 

(730)

 

(1,580)

 

(2,286)

Other non-cash adjustments

 

538

 

(220)

 

(291)

 

(156)

 

(180)

 

27

 

(430)

Cash revenue from dispositions

 

1

 

(2,097)

 

—

 

(172)

 

(452)

 

(2,096)

 

(3,759)

Cash revenue attributable to noncontrolling interests (1)

 

(2,127)

 

(475)

 

(481)

 

(470)

 

(472)

 

(3,083)

 

(1,399)

Cash revenue (1)

 

740,264

 

670,955

 

649,222

 

602,489

 

571,103

 

2,060,441

 

1,648,169

Debt investments (2)

 

(2,771)

 

(1,171)

 

(1,158)

 

(1,167)

 

(1,165)

 

(5,100)

 

(3,809)

Revenue attributable to new acquisitions/dispositions/other

 

(265,769)

 

(217,189)

 

(194,108)

 

(152,303)

 

(125,347)

 

(677,066)

 

(343,858)

Revenue attributable to development conversion

 

(1,105)

 

(1,014)

 

(904)

 

(897)

 

(864)

 

(3,023)

 

(2,255)

Revenue attributable to Non-Core Properties

 

(6,013)

 

(5,946)

 

(9,194)

 

(9,300)

 

(9,622)

 

(21,153)

 

(28,634)

Other normalizing revenue adjustments

 

(7,772)

 

—

 

(354)

 

—

 

—

 

(8,126)

 

(522)

Same-Store revenue (1)

 

$456,834

 

$445,635

 

$443,504

 

$438,822

 

$434,105

 

$1,345,973

 

$1,269,091

 

(1)

All periods are based upon current quarter's ownership percentage.

 

 

 

 

 

 

 

(2)

Relates to debt security investment and debt investment within Triple-Net Leased Properties.

 

 

 

 

 

 

 

 

American Healthcare REIT | Q3 2026 Supplemental | Page 22


 

Same-Store NOI Reconciliation

img33188571_15.jpg

(in thousands)

 

 

Q3 2026

 

Q2 2026

 

Q1 2026

 

Q4 2025

 

Q3 2025

 

YTD 9/30/26

 

YTD 9/30/25

Integrated Senior Health Campuses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOI

 

$90,047

 

$78,159

 

$71,759

 

$63,930

 

$62,168

 

$239,965

 

$176,093

Facility rental expense

 

6,752

 

6,752

 

6,761

 

6,849

 

7,030

 

20,265

 

21,807

Cash NOI from dispositions

 

—

 

(328)

 

—

 

—

 

1

 

(328)

 

(472)

Cash NOI

 

96,799

 

84,583

 

78,520

 

70,779

 

69,199

 

259,902

 

197,428

New acquisitions/dispositions/other

 

(16,039)

 

(12,727)

 

(9,933)

 

(5,852)

 

(6,538)

 

(38,699)

 

(12,464)

Non-Core Properties

 

(510)

 

(506)

 

(912)

 

(1,011)

 

(1,078)

 

(1,928)

 

(2,822)

Other normalizing adjustments

 

(7,772)

 

—

 

—

 

—

 

1,044

 

(7,772)

 

1,044

Same-Store NOI

 

$72,478

 

$71,350

 

$67,675

 

$63,916

 

$62,627

 

$211,503

 

$183,186

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SHOP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOI

 

$46,209

 

$31,522

 

$25,837

 

$19,764

 

$15,360

 

$103,568

 

$41,188

Other non-cash adjustments

 

102

 

—

 

—

 

—

 

—

 

102

 

—

Cash NOI from dispositions

 

—

 

—

 

—

 

4

 

24

 

—

 

88

Cash NOI attributable to noncontrolling interests (1)

 

(536)

 

(55)

 

(57)

 

(57)

 

(58)

 

(648)

 

(185)

Cash NOI (1)

 

45,775

 

31,467

 

25,780

 

19,711

 

15,326

 

103,022

 

41,091

New acquisitions/dispositions

 

(28,092)

 

(15,329)

 

(11,408)

 

(6,089)

 

(1,921)

 

(54,829)

 

(2,771)

Development conversion

 

(104)

 

(19)

 

330

 

301

 

343

 

207

 

980

Non-Core Properties

 

(24)

 

(32)

 

(66)

 

16

 

(59)

 

(122)

 

(176)

Other normalizing adjustments

 

—

 

—

 

—

 

—

 

—

 

—

 

147

Same-Store NOI (1)

 

$17,555

 

$16,087

 

$14,636

 

$13,939

 

$13,689

 

$48,278

 

$39,271

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outpatient Medical

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOI

 

$18,573

 

$18,492

 

$18,718

 

$18,717

 

$19,128

 

$55,783

 

$58,699

Straight line rent

 

24

 

(100)

 

(358)

 

(363)

 

(243)

 

(434)

 

(675)

Other non-cash adjustments

 

(68)

 

(111)

 

(203)

 

(55)

 

(85)

 

(382)

 

(162)

Cash NOI from dispositions

 

(6)

 

—

 

10

 

23

 

(127)

 

4

 

(332)

Cash NOI

 

18,523

 

18,281

 

18,167

 

18,322

 

18,673

 

54,971

 

57,530

Dispositions

 

—

 

—

 

—

 

—

 

83

 

—

 

(1,763)

Non-Core Properties

 

(956)

 

(890)

 

(918)

 

(898)

 

(1,259)

 

(2,764)

 

(4,183)

Other normalizing adjustments

 

—

 

—

 

—

 

318

 

—

 

—

 

—

Same-Store NOI

 

$17,567

 

$17,391

 

$17,249

 

$17,742

 

$17,497

 

$52,207

 

$51,584

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Triple-Net Leased Properties

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOI

 

$9,966

 

$9,066

 

$9,189

 

$9,169

 

$9,159

 

$28,221

 

$27,600

Straight line rent

 

(321)

 

(403)

 

(422)

 

(430)

 

(487)

 

(1,146)

 

(1,611)

Other non-cash adjustments

 

900

 

188

 

217

 

218

 

218

 

1,305

 

679

Cash NOI from dispositions

 

—

 

(27)

 

—

 

—

 

—

 

(27)

 

—

Cash NOI attributable to noncontrolling interest (1)

 

(198)

 

(195)

 

(193)

 

(193)

 

(193)

 

(586)

 

(573)

Cash NOI (1)

 

10,347

 

8,629

 

8,791

 

8,764

 

8,697

 

27,767

 

26,095

Debt investments (2)

 

(2,771)

 

(1,171)

 

(1,158)

 

(1,167)

 

(1,165)

 

(5,100)

 

(3,809)

Dispositions

 

—

 

—

 

—

 

—

 

—

 

—

 

3

Non-Core Properties

 

—

 

—

 

(159)

 

(157)

 

(157)

 

(159)

 

(464)

Same-Store NOI (1)

 

$7,576

 

$7,458

 

$7,474

 

$7,440

 

$7,375

 

$22,508

 

$21,825

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Portfolio

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOI

 

$164,795

 

$137,239

 

$125,503

 

$111,580

 

$105,815

 

$427,537

 

$303,580

Straight line rent

 

(297)

 

(503)

 

(780)

 

(793)

 

(730)

 

(1,580)

 

(2,286)

Facility rental expense

 

6,752

 

6,752

 

6,761

 

6,849

 

7,030

 

20,265

 

21,807

Other non-cash adjustments

 

934

 

77

 

14

 

163

 

133

 

1,025

 

517

Cash NOI from dispositions

 

(6)

 

(355)

 

10

 

27

 

(102)

 

(351)

 

(716)

Cash NOI attributable to noncontrolling interests (1)

 

(734)

 

(250)

 

(250)

 

(250)

 

(251)

 

(1,234)

 

(758)

Cash NOI (1)

 

171,444

 

142,960

 

131,258

 

117,576

 

111,895

 

445,662

 

322,144

Debt investments (2)

 

(2,771)

 

(1,171)

 

(1,158)

 

(1,167)

 

(1,165)

 

(5,100)

 

(3,809)

New acquisitions/dispositions/other

 

(44,131)

 

(28,056)

 

(21,341)

 

(11,941)

 

(8,376)

 

(93,528)

 

(16,995)

Development conversion

 

(104)

 

(19)

 

330

 

301

 

343

 

207

 

980

Non-Core Properties

 

(1,490)

 

(1,428)

 

(2,055)

 

(2,050)

 

(2,553)

 

(4,973)

 

(7,645)

Other normalizing adjustments

 

(7,772)

 

—

 

—

 

318

 

1,044

 

(7,772)

 

1,191

Same-Store NOI (1)

 

$115,176

 

$112,286

 

$107,034

 

$103,037

 

$101,188

 

$334,496

 

$295,866

 

 

 

 

 

 

(1)

All periods are based upon current quarter's ownership percentage.

 

 

 

 

 

 

 

(2)

Relates to debt security investment and debt investment within Triple-Net Leased Properties.

 

 

 

 

 

 

 

 

American Healthcare REIT | Q3 2026 Supplemental | Page 23


 

Defined Terms

img33188571_16.jpg

•
Adjusted EBITDA: EBITDA excluding the impact of income or loss from unconsolidated entities, straight line rent and amortization of above/below market leases, non-cash impact of changes to equity instruments, transaction, transition and restructuring costs, gain or loss on dispositions of real estate investments, amortization of direct origination and closing costs on debt investments, unrealized foreign currency gain or loss, change in fair value of derivative financial instruments, impairments of real estate investments, impairments of intangible assets and goodwill, and non-recurring and/or one-time items.
•
Affiliated: An OM (as defined on the next page) that, as of a specified date, has 25.0% or more of its square footage occupied by at least one healthcare system.
•
AL: Assisted living units.
•
Annualized Adjusted EBITDA: Current period (shown as quarterly) Adjusted EBITDA multiplied by four.
•
Annualized Cash NOI: Current quarter Cash NOI multiplied by four.
•
ABR: Annualized Base Rent. ABR is calculated as contractual base rent for the last month of the applicable period multiplied by 12.
•
Cash NOI: NOI excluding the impact of, without duplication, (1) non-cash items such as straight-line rent and the amortization of lease intangibles, (2) third-party facility rent payments and (3) other items set forth in the Cash NOI reconciliation included herein. Both Cash NOI and Same-Store NOI include Pro-Rata ownership and other adjustments.
•
Cash NOI Margin: Calculated by dividing Cash NOI by cash revenue.
•
EBITDA: A non-GAAP financial measure that is defined as earnings before interest, taxes, depreciation and amortization.
•
EBITDAR: Earnings before interest, taxes, depreciation, amortization and facilities rent. We use unaudited, periodic financial information provided solely by tenants to calculate EBITDAR and have not independently verified the information.
•
EBITDAR Coverage: The ratio of EBITDAR to contractual rent for leases or interest and principal payments for loans. EBITDAR Coverage is a measure of a property’s ability to generate sufficient cash flows for the operator/borrower to pay rent and meet other obligations.
•
EBITDARM: Earnings before interest, taxes, depreciation, amortization, facilities rent and management fees. We use unaudited, periodic financial information provided solely by tenants to calculate EBITDARM and have not independently verified the information.
•
EBITDARM Coverage: The ratio of EBITDARM to contractual rent for leases or interest and principal payments for loans. EBITDARM Coverage is a measure of a property’s ability to generate sufficient cash flows for the operator or borrower to pay rent and meet other obligations, assuming that management fees are not paid.
•
ExPOR: Expense per occupied unit. ExPOR is calculated as total expense generated by occupied units divided by the number of occupied units.
•
GAAP Revenue: Revenue recognized in accordance with Generally Accepted Accounting Principles in the United States (“GAAP”), which includes straight line rent and other non-cash adjustments.
•
GLA: Gross leasable area.
•
Hospitals: Hospital properties typically will include acute care, long-term acute care, specialty and rehabilitation hospitals and generally will be leased to single tenants or operators under triple-net lease structures.
•
IL: Independent living units.
•
Integrated Senior Health Campuses or ISHC: Integrated senior health campuses include a range of senior care, including independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. Integrated senior health campuses are operated utilizing a RIDEA Structure (as defined on the next page).
•
Maintenance Capex: AHR-invested capital expenditures, whether routine or non-routine (including second generation tenant incentives and leasing commissions), that are not expected to generate incremental income for the Company.
•
MC: Memory care units.

American Healthcare REIT | Q3 2026 Supplemental | Page 24


 

Defined Terms, continued

img33188571_16.jpg

•
NAREIT FFO or FFO: Funds from operations attributable to controlling interest; a non-GAAP financial measure, consistent with the standards established by the White Paper on FFO approved by the Board of Governors of NAREIT (the “White Paper”). The White Paper defines FFO as net income (loss) computed in accordance with GAAP, excluding gains or losses from dispositions of certain real estate assets, gains or losses upon consolidation of a previously held equity interest, and impairment write-downs of certain real estate assets and investments, plus depreciation and amortization related to real estate, after adjustments for unconsolidated partnerships and joint ventures. While impairment charges are excluded from the calculation of FFO as described above, investors are cautioned that impairments are based on estimated future undiscounted cash flows. Adjustments for unconsolidated partnerships and joint ventures are calculated to reflect FFO.
•
NAV: Net asset value.
•
Net Debt: Total Debt, excluding operating lease liabilities, less cash and cash equivalents and restricted cash related to debt.
•
NOI: Net operating income; a non-GAAP financial measure that is defined as net income (loss), computed in accordance with GAAP, generated from properties before general and administrative expenses, transaction, transition and restructuring costs, depreciation and amortization, interest expense, gain or loss in fair value of derivative financial instruments, gain or loss on dispositions of real estate investments, impairment of real estate investments, impairment of intangible assets and goodwill, income or loss from unconsolidated entities, gain on re-measurement of previously held equity interest, foreign currency gain or loss, other income or expense and income tax benefit or expense.
•
Non-Core Properties: Assets that have been deemed not essential to generating future economic benefit or value to our day-to-day operations and/or are projected to be sold.
•
Normalized FFO or NFFO: FFO further adjusted for the following items included in the determination of GAAP net income (loss): transaction, transition and restructuring costs; amounts relating to changes in deferred rent and amortization of above and below-market leases (which are adjusted in order to reflect such payments from a GAAP accrual basis); the non-cash impact of changes to our equity instruments; non-cash or non-recurring income or expense; the non-cash effect of income tax benefits or expenses; capitalized interest; impairment of intangible assets and goodwill; amortization of direct origination and closing costs on debt investments; mark-to-market adjustments included in net income (loss); gains or losses included in net income (loss) from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or securities holdings where trading of such holdings is not a fundamental attribute of the business plan; and after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect Normalized FFO on the same basis.
•
Occupancy: With respect to OM, the percentage of total rentable square feet leased and occupied, including month-to-month leases, as of the date reported. With respect to all other property types, occupancy represents average quarterly operating occupancy based on the most recent quarter of available data. The Company uses unaudited, periodic financial information provided solely by tenants to calculate occupancy and has not independently verified the information.
•
OM: Outpatient Medical properties.
•
OP Unit: Units of limited partnership interest in the Operating Partnership, which are redeemable for cash or, at our election, shares of our common stock on a one-for-one basis, subject to certain adjustments.
•
Operating Partnership: American Healthcare REIT Holdings, LP, a Delaware limited partnership, through which we conduct substantially all of our business and of which Continental Merger Sub, LLC, a Delaware limited liability company and our wholly-owned subsidiary, is the sole general partner.
•
Pro-Rata: As of September 30, 2026, we owned and/or operated buildings/properties through entities of which we owned less than 100% of the ownership interests. Because we have a controlling interest in these entities, these entities and the properties these entities own are consolidated in our financial statements in accordance with GAAP. However, while such properties are presented in our financial statements on a consolidated basis, we are only entitled to our Pro-Rata share of the net cash flows generated by such properties. As a result, we have presented certain property information herein based on our Pro-Rata ownership interest in these entities and the properties these entities own, as of the applicable date, and not on a consolidated basis. In such instances, information is noted as being presented on a “Pro-Rata share” basis.
•
Quality Mix: Total number of Medicare, Managed Care, Medicare Advantage and private days or revenue divided by the total number of actual patient days or total revenue for all payor types within Skilled Nursing and Senior Housing beds in the ISHC segment.
•
Retention: The ratio of total renewed square feet and month-to-month leases retained to the total square feet expiring, excluding the square feet for tenant leases terminated and leases in assets expected to be sold for the trailing 12-months.
•
RevPOR: Revenue per occupied room. RevPOR is calculated as total revenue generated by occupied units divided by the number of occupied units.

American Healthcare REIT | Q3 2026 Supplemental | Page 25


 

Defined Terms, continued

img33188571_16.jpg

•
RIDEA Structure: A structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, pursuant to which we lease certain healthcare real estate properties to a wholly-owned taxable REIT subsidiary (TRS), which in turn contracts with an eligible independent contractor (EIK) to operate such properties for a fee. Under this structure, the EIK receives management fees, and the TRS receives revenue from the operation of the healthcare real estate properties and retains, as profit, any revenue remaining after payment of expenses (including intercompany rent paid to us and any taxes at the TRS level) necessary to operate the property. Through the RIDEA Structure, in addition to receiving rental revenue from the TRS, we retain any after-tax profit from the operation of the healthcare real estate properties and benefit from any improved operational performance while bearing the risk of any decline in operating performance at the properties.
•
Same-Store: Properties owned or consolidated the full year in both comparison years and that are not otherwise excluded. Properties are excluded from Same-Store if they are: (1) sold, classified as held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (2) impacted by materially disruptive events, such as flood or fire for an extensive period of time; or (3) scheduled to undergo or currently undergoing major expansions/renovations or business model transitions or have transitioned business models after the start of the prior comparison period.
•
Same-Store NOI: Cash NOI for our Same-Store properties. Same-Store NOI is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. Both Cash NOI and Same-Store NOI include ownership and other adjustments.
•
Same-Store NOI Margin: Calculated by dividing Same-Store NOI by Same-Store revenue.
•
Senior Housing-Leased: Senior housing facilities cater to different segments of the elderly population based upon their personal needs and include assisted living, memory care and independent living. Residents of assisted living facilities typically require limited medical care and need assistance with eating, bathing, dressing and/or medication management, and those services can be provided by staff at the facility. Resident programs offered at such facilities may include transportation, social activities and exercise and fitness programs. Our Senior Housing-Leased properties are triple-net leased.
•
SHOP: Senior housing operating properties.
•
SHOP+: Consists of the SHOP and ISHC segments.
•
SNFs: Skilled nursing facilities.
•
Square Feet or Sq. Ft.: Net rentable square feet calculated utilizing building owners and managers association measurement standards.
•
Total Debt: The principal balances of the Company’s revolving credit facilities, term loan and secured indebtedness as reported in the Company’s consolidated financial statements.
•
Triple-Net Leased: A lease where the tenant is responsible for making rent payments, maintaining the leased property, and paying property taxes and other expenses.
•
WALT: Weighted average lease term.

 

American Healthcare REIT | Q3 2026 Supplemental | Page 26


 

 

img33188571_17.jpg

https://www.americanhealthcarereit.com

 

 

18191 Von Karman Avenue, Suite 300

Irvine, California

 

American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing communities, skilled nursing, and outpatient medical buildings across the United States, and in the United Kingdom and the Isle of Man.

 

img33188571_18.gif

American Healthcare REIT | Q3 2026 Supplemental | Page 27